Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Netherlands
Clinical trial register · Netherlands

Clinical Trials in the Netherlands

Every study on the ClinicalTrials.gov registry that lists a site in Netherlands and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 3171 matching records held by the registry are in this view. Synced 10 Nov 2026, 03:17 UTC
3171
Studies in scope
all four open statuses
1789
Recruiting now
open to new participants
601
Lead sponsors
across recruiting studies
Top sites
Amsterdam 1239 Rotterdam 853 Groningen 601 Nijmegen 565 Utrecht 543
Narrow the register
Recruitment status
Phase
Lead sponsor
Erasmus Medical Center153 University Medical Center Groningen133 Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)133 Radboud University Medical Center108 AstraZeneca87 Maastricht University Medical Center80 Leiden University Medical Center77 Novartis Pharmaceuticals75 The Netherlands Cancer Institute70 Merck Sharp & Dohme LLC64 UMC Utrecht64 Janssen Research & Development, LLC61 Amsterdam UMC, location VUmc60 Eli Lilly and Company44 Boehringer Ingelheim37 AbbVie35 Sanofi35 Bristol-Myers Squibb33 Hoffmann-La Roche30 GlaxoSmithKline27 Novo Nordisk A/S25 Pfizer24 Amgen24 European Organisation for Research and Treatment of Cancer - EORTC22 St. Antonius Hospital22 Stichting Hemato-Oncologie voor Volwassenen Nederland21 Maastricht Radiation Oncology17 Genmab16 Daiichi Sankyo16 Bayer16 Incyte Corporation16 Abbott Medical Devices15 Wageningen University15 Rijnstate Hospital14 Takeda14 argenx14 Vertex Pharmaceuticals Incorporated13 Princess Maxima Center for Pediatric Oncology12 Boston Scientific Corporation12 Zuyderland Medisch Centrum11 Franciscus Gasthuis11 Catharina Ziekenhuis Eindhoven11 Alnylam Pharmaceuticals11 Regeneron Pharmaceuticals9 Medisch Spectrum Twente9 Maxima Medical Center9 Gilead Sciences9 Seagen, a wholly owned subsidiary of Pfizer8 W.L.Gore & Associates8 JointResearch8 University Hospital, Basel, Switzerland8 Amsterdam UMC8 Exelixis8 Alexion Pharmaceuticals, Inc.8 Celgene8 AO Innovation Translation Center7 Maastricht University7 Agios Pharmaceuticals, Inc.7 Universitaire Ziekenhuizen KU Leuven7 Medtronic Cardiovascular7 Ionis Pharmaceuticals, Inc.7 BeOne Medicines7 Institut de Recherches Internationales Servier6 VU University of Amsterdam6 Reinier Haga Orthopedisch Centrum6 Zimmer Biomet6 Mirati Therapeutics Inc.6 European Myeloma Network B.V.6 Astellas Pharma Global Development, Inc.6 Universiteit Leiden6 Tilburg University6 Sint Maartenskliniek6 University of Birmingham5 Population Health Research Institute5 Revolution Medicines, Inc.5 ModernaTX, Inc.5 Vascutek Ltd.5 Genentech, Inc.5 Medtronic5 University of Amsterdam5 Biogen5 University of Twente5 Deciphera Pharmaceuticals, LLC5 ETOP IBCSG Partners Foundation5 Isala5 Gustave Roussy, Cancer Campus, Grand Paris5 Denali Therapeutics Inc.5 Jasper Gerritsen5 Ultragenyx Pharmaceutical Inc5 Washington University School of Medicine5 Kite, A Gilead Company4 Oslo University Hospital4 University of Oxford4 Intellia Therapeutics4 Aragon Pharmaceuticals, Inc.4 Jaeb Center for Health Research4 M.A. Med Alliance S.A.4 Pierre Fabre Medicament4 Borstkanker Onderzoek Groep4 Copenhagen University Hospital, Rigshospitalet4 UNICANCER4 Martini Hospital Groningen4 Italfarmaco4 Alkermes, Inc.4 CSL Behring4 De Viersprong4 Edwards Lifesciences4 Institut National de la Santé Et de la Recherche Médicale, France4 ViiV Healthcare4 Acerta Pharma BV4 Haaglanden Medical Centre4 Spaarne Gasthuis4 Philips Clinical & Medical Affairs Global3 Karakter Kinder- en Jeugdpsychiatrie3 Assistance Publique - Hôpitaux de Paris3 Ggz Oost Brabant3 University Medical Center Nijmegen3 Stichting European Myeloma Network3 Avidity Biosciences, Inc.3 Nuvalent Inc.3 The Hospital for Sick Children3 Dianthus Therapeutics3 Zealand Pharma3 University of Zurich3 GRIN Therapeutics, Inc.3 Xenon Pharmaceuticals Inc.3 Cathreine BV3 IRCCS San Raffaele3 Mirum Pharmaceuticals, Inc.3 Blueprint Medicines Corporation3 Vrije Universiteit Brussel3 Miltenyi Biomedicine GmbH3 DePuy Orthopaedics3 Academisch Ziekenhuis Maastricht3 ReCor Medical, Inc.3 Memorial Sloan Kettering Cancer Center3 Institut für Pharmakologie und Präventive Medizin3 Comprehensive Cancer Centre The Netherlands3 University Hospital, Ghent3 Basilea Pharmaceutica3 Roessingh Research and Development3 ARQ National Psychotrauma Centre3 Karyopharm Therapeutics Inc3 Medtronic Cardiac Surgery3 Reinier de Graaf Groep3 Nutricia Research3 Leiden University3 Corsano Health B.V.3 Charite University, Berlin, Germany3 Universitätsklinikum Hamburg-Eppendorf3 IDEAYA Biosciences3 Universitair Ziekenhuis Brussel3 EMD Serono Research & Development Institute, Inc.3 Genzyme, a Sanofi Company3 Alfasigma S.p.A.3 Insel Gruppe AG, University Hospital Bern3 JOTEC GmbH3 BioNTech SE3 Cogent Biosciences, Inc.3 Otsuka Pharmaceutical Development & Commercialization, Inc.3 BioMarin Pharmaceutical2 University of Kansas Medical Center2 Albireo, an Ipsen Company2 CoreAalst BV2 University of Cologne2 Utrecht University2 University of Pennsylvania2 Rigel Pharmaceuticals2 Immunovant Sciences GmbH2 Cytokinetics2 Pulmair Medical, Inc.2 Fondazione SISA (Societa Italiana per lo Studio della Arteriosclerosi)2 Calico Life Sciences LLC2 Accare2 Parnassia Groep2 Jazz Pharmaceuticals2 Merit Medical Systems, Inc.2 Jennifer Breel2 Corcept Therapeutics2 NewAmsterdam Pharma2 Weill Medical College of Cornell University2 Janssen Pharmaceutica N.V., Belgium2 Alimentiv Inc.2 Meander Medical Center2 MedImmune LLC2 Shape Memory Medical, Inc.2 Neurocrine Biosciences2 Canisius-Wilhelmina Hospital2 European Clinical Research Alliance for Infectious Diseases (ECRAID)2 Jord Vink2 Creo Medical Limited2 Deventer Ziekenhuis2 Meril Life Sciences Pvt. Ltd.2 University of Groningen2 Servier Affaires Médicales2 Cochlear2 University of Aarhus2 Day One Biopharmaceuticals, Inc.2 Pharming Technologies B.V.2 Inhibrx Biosciences, Inc2 Alliance for Clinical Trials in Oncology2 Medtronic Vascular2 Ataxia Study Group2 Imricor Medical Systems2 dr. M.J.N.L. Benders2 ALX Oncology Inc.2 Apellis Pharmaceuticals, Inc.2 Sahlgrenska University Hospital2 MicroPort CRM2 Onze Lieve Vrouwe Gasthuis2 Byondis B.V.2 Vertero Therapeutics2 Thomas Jefferson University2 Pharvaris Netherlands B.V.2 Telix Pharmaceuticals (Innovations) Pty Limited2 Hospital Universitari Vall d'Hebron Research Institute2 Taiho Oncology, Inc.2 Haukeland University Hospital2 Vir Biotechnology, Inc.2 Region Skane2 Jeroen van Eijk2 Juno Therapeutics, Inc., a Bristol-Myers Squibb Company2 Daniel Keszthelyi2 Longboard Pharmaceuticals2 CVRx, Inc.2 dr. Laura C. G. de Graaff-Herder2 Prilenia2 Arkin2 Nationwide Children's Hospital2 Calcilytix Therapeutics, Inc., a BridgeBio company2 Amsterdam University Medical Centers (UMC), Location Academic Medical Center (AMC)2 HAN University of Applied Sciences2 Kardigan, Inc.2 Camurus AB2 Behavioural Science Institute2 CUTISS AG2 Laboratoires Thea2 Abivax S.A.2 Stemline Therapeutics, Inc.2 Indiana University2 ML Bio Solutions, Inc.2 Immunocore Ltd2 Olema Pharmaceuticals, Inc.2 Santen SAS2 TripleMed B.V.2 Galvani Bioelectronics2 Eidos Therapeutics, a BridgeBio company2 Arcus Biosciences, Inc.2 Celldex Therapeutics2 Dr. Mark Mulder2 Vastra Gotaland Region2 General Practitioners Research Institute2 AC Immune SA2 Istituto Giannina Gaslini2 Centre for Human Drug Research, Netherlands2 Salvia BioElectronics2 Sarepta Therapeutics, Inc.2 Crinetics Pharmaceuticals Inc.2 Mediar Therapeutics2 Tergooi Medical Center2 Isabelle Henskens2 Scholar Rock, Inc.2 Verastem, Inc.2 Medtronic MiniMed, Inc.2 Apreo Health, Inc.2 ITM Solucin GmbH2 DBV Technologies2 Enliven Therapeutics2 United Therapeutics2 Iovance Biotherapeutics, Inc.2 Avalyn Pharma Inc.2 Medtronic Cardiac Ablation Solutions2 Alzheimercentrum Amsterdam2 PedAL BCU, LLC2 Frisius Medisch Centrum2 Entrada Therapeutics, Inc.2 R&D Cardiologie2 M.R. Meijerink2 University of Ulm2 Viridian Therapeutics, Inc.2 Biohaven Therapeutics Ltd.2 Dyne Therapeutics2 University Hospital, Geneva2 Children's Oncology Group2 Astria Therapeutics, Inc.2 Bart Koes2 ArriVent BioPharma, Inc.2 Parnassia Addiction Research Centre2 Albert Schweitzer Ziekenhuis, Netherlands2 Chugai Pharmaceutical2 USWM CT, LLC2 Loxo Oncology, Inc.2 Amicus Therapeutics2 Michael J. Fox Foundation for Parkinson's Research2 Wageningen University and Research2 Tesaro, Inc.2 University Hospital, Gasthuisberg2 Syndax Pharmaceuticals2 K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc1 BioAegis Therapeutics Inc.1 University College, London1 ADC Therapeutics S.A.1 Toronto Metropolitan University1 University of California, San Francisco1 Philipp Dutkowski1 Biotronik AG1 The POLG Foundation1 MedSIR1 Institute Verbeeten1 Genetix Biotherapeutics Inc.1 VDI Technologies1 XVIVO Perfusion1 SynOx Therapeutics Limited1 VieCuri Medical Centre1 Annemie Spooren1 Leal Therapeutics, Inc1 Niek Wijnen1 Molecure S.A.1 Icahn School of Medicine at Mount Sinai1 Vesalio1 Almirall, S.A.1 M.D. Anderson Cancer Center1 Nick Beije1 NeuroDerm Ltd.1 University of Massachusetts, Worcester1 IDRX, Inc., a wholly owned subsidiary of GSK, LLC1 DeuterOncology1 University of Utah1 Zaandam Medical Center1 Nyxoah S.A.1 Mattienne van der Kamp1 Dimitri Diavatopoulos1 Cullinan Therapeutics Inc.1 Rare Thyroid Therapeutics International AB1 Michele van Vugt1 BrioHealth BV1 AtaCor Medical, Inc.1 Majanka H. Heijenbrok-Kal, PhD1 Curadel Surgical Innovations, Inc.1 Cortex1 Omeros Corporation1 Surgimab1 Ivy Brain Tumor Center1 Franciscus Gasthuis & Vlietland (Hospital)1 Geestelijke Gezondheidszorg Eindhoven (GGzE)1 Corvia Medical1 Royal Dutch Visio1 Claudia Schuurhuizen1 PROspective Renal Cancer Cohort Foundation1 Fondazione IRCCS Istituto Nazionale dei Tumori, Milano1 Rocket Pharmaceuticals Inc.1 HagaZiekenhuis1 National University of Ireland, Galway, Ireland1 Amsterdam University Medical Center1 University of Roma La Sapienza1 University Hospital, Tours1 Fondazione Ricerca e Innovazione Cardiovascolare ETS1 Dutch Society of Physicians for Pulmonology and Tuberculosis1 D.J. (Dirk) Grünhagen1 Marieke Goodijk1 Genethon1 Shionogi1 Pulse Biosciences, Inc.1 Vivasure Medical Limited1 Portsmouth Hospitals NHS Trust1 Neurimmune AG1 Calluna Pharma AS1 Integrum1 University of Glasgow1 Hamilton Health Sciences Corporation1 Occlutech International AB1 University of Leicester1 SECRETO Study Consortium1 Khondrion BV1 Rotkreuzklinikum München gGmbH1 Bolt Medical1 ProQR Therapeutics1 Vaderis Therapeutics AG1 Janneke van de Wijgert1 Algernon Pharmaceuticals1 Disc Medicine, Inc1 Nura Bio1 Noah Labs1 Actuate Therapeutics Inc.1 Koen Rovers1 University of Leeds1 Terumo Europe N.V.1 Stanford University1 Virginia Commonwealth University1 Klimmendaal Revalidatiespecialisten1 Biohaven Pharmaceuticals, Inc.1 RHEACELL GmbH & Co. KG1 Casper Rokx1 University of Exeter1 University of Liege1 NovoCure Ltd.1 Neuspera Medical, Inc.1 OncoC4, Inc.1 Roxanne Gal1 Zai Lab (Shanghai) Co., Ltd.1 Willeke Boonstra1 Davy van de Sande1 University of Washington1 VarmX B.V.1 Dutch Colorectal Cancer Group1 Marc Bosiers, MD1 Lucid Diagnostics, Inc.1 Amsterdam University of Applied Sciences1 Angela HUTTNER1 Alliance Foundation Trials, LLC.1 Dompé Farmaceutici S.p.A1 Edgewise Therapeutics, Inc.1 AVEO Pharmaceuticals, Inc.1 University of California, Los Angeles1 European Society of Cardiology1 Marjolein Spiering1 Luuk Stapersma1 University Hospital Tuebingen1 Candela Corporation1 ARTHEx Biotech S.L.1 Natasha Appelman-Dijkstra1 Aleksander Krag1 Eduard Verheijen1 Massachusetts General Hospital1 Jasper Brugts MD PhD1 Orchestra BioMed, Inc1 Diakonessenhuis, Utrecht1 Atrial Fibrillation Network1 Norwegian University of Science and Technology1 Inspire Medical Systems, Inc.1 Ryme Medical, Inc.1 Copenhagen Trial Unit, Center for Clinical Intervention Research1 Jip Groen1 Shanghai Henlius Biotech1 Abbisko Therapeutics Co, Ltd1 EBR Systems, Inc.1 Proctos Kliniek1 NovoCure GmbH1 Friedreich's Ataxia Research Alliance1 Prof. Valérie Mc Lin1 European Foundation for Study of Chronic Liver Failure1 dr. P. Noordzij1 Relay Therapeutics, Inc.1 Atos Medical AB1 University of Melbourne1 Willem de Haan1 Prevail Therapeutics1 Gynaecologisch Oncologisch Centrum Zuid1 Oticon Medical1 Bioverativ, a Sanofi company1 Biogem s.c.ar.l.1 Alpine Immune Sciences Inc, A Subsidiary of Vertex1 Meyer Children's Hospital IRCCS1 Anders Perner1 International Extranodal Lymphoma Study Group (IELSG)1 Denise van Diermen1 Hasselt University1 Gossamer Bio USA, Inc.1 Fontys University of Applied Sciences1 AvenCell Europe GmbH1 Marc van Det1 KU Leuven1 Prospective Bladder Cancer Infrastructure Foundation1 Frank G. Holz1 Mundipharma Research Limited1 Christian S. Meyhoff1 Janssen-Cilag Ltd.1 GGZ Noord-Holland-Noord1 Advanced Accelerator Applications1 Cook Research Incorporated1 Fore Biotherapeutics1 Britannia Pharmaceuticals Ltd.1 Generate Biomedicines1 Koen Munters1 PedNet Haemophilia Research Foundation1 Eupraxia Pharmaceuticals Inc.1 Endospan Ltd.1 Azalea Vision1 Mara Veenstra, MD1 Centre Leon Berard1 Respicardia, Inc.1 Matthias Stuber1 Nyika D. Kruyt1 Hansa Biopharma AB1 University Hospital, Essen1 Coloplast A/S1 Ludwig-Maximilians - University of Munich1 Bordeaux Colorectal Institute Academy1 VectivBio AG1 Ipsen1 BioNTech Cell & Gene Therapies GmbH1 Corcym S.r.l1 Nurix Therapeutics, Inc.1 Linda Douw1 Anocca AB1 J. W. A. Burger1 Rapamycin Holdings Inc.1 Epics Therapeutics1 Santhera Pharmaceuticals1 AriBio Co., Ltd.1 Philipp Homan1 Saluda Medical Pty Ltd1 RayzeBio, Inc.1 CeleCor Therapeutics1 Zogenix, Inc.1 NHS Greater Glasgow and Clyde1 Mark C Burgmans, MD PhD1 Institut universitaire de cardiologie et de pneumologie de Québec, University Laval1 Society of Interventional Oncology1 Ziekenhuis Oost-Limburg1 JL Tol1 Stereotaxis1 Maria Joyera Rodríguez1 Hanneke W. M. van Laarhoven1 GEN İlaç ve Sağlık Ürünleri A.Ş.1 Zenas BioPharma (USA), LLC1 Nantes University Hospital1 SPCTR1 Arga Medtech SA1 Cyril Camaro1 Fondazione IRCCS Policlinico San Matteo di Pavia1 Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III1 M. Medici1 Janssen-Cilag International NV1 dr Pim A.L. Tonino1 NS Pharma, Inc.1 Vall d'Hebron Institute of Oncology1 Jubaan Ltd.1 Italian Sarcoma Group1 Electra Therapeutics Inc.1 AtriCure, Inc.1 Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan1 EP Solutions SA1 Maasstad Hospital1 Vector Y Therapeutics1 RyCarma Therapeutics, Inc.1 Institute of Cancer Research, United Kingdom1 Travere Therapeutics, Inc.1 eleva GmbH1 David Palma1 Erasca, Inc.1 Children's Hospital of Philadelphia1 Hemab ApS1 University of Edinburgh1 Fundació d'investigació Sanitària de les Illes Balears1 Association NVALT Studies1 Iambic Therapeutics, Inc1 JCR Pharmaceuticals Co., Ltd.1 Canadian Cancer Trials Group1 AnaptysBio, Inc.1 Tyra Biosciences, Inc1 Aarhus University Hospital1 Instituto de Investigación Biomédica de Salamanca1 University Hospital Muenster1 Beam Therapeutics Inc.1 InnoCon Medical1 Goed Medisch Centrum1 FCRE (Foundation for Cardiovascular Research and Education)1 BioCryst Pharmaceuticals1 Wim Janssens1 Promedius Inc1 University Hospital Heidelberg1 Sirius Medical Systems B.V.1 OSE Immunotherapeutics1 Zoll Medical Corporation1 Joost J. M. E. Nuyttens1 Pulmovant, Inc.1 Happitech BV1 Inventiva Pharma1 Unity Health Toronto1 GGZ Centraal1 Ancora Heart, Inc.1 Sabine Mueller, MD, PhD1 Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany1 BioProtect1 SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany1 LMU Klinikum1 Xcovery Holdings, Inc.1 European LeukemiaNet1 Christian Dorfer1 V-Wave Ltd1 Mineralys Therapeutics Inc.1 Helsinki University Central Hospital1 NVT GmbH1 Janine M. Simons MD PhD1 JenaValve Technology, Inc.1 LEO Pharma1 Vitestro B.V.1 Prof. Dr. Folkert W. Asselbergs1 ProJenX1 Weizmann Institute of Science1 Biosense Webster, Inc.1 Partner Therapeutics, Inc.1 Replasia BV1 ORNND - Operating Room Nurse Network Denmark1 Altrecht1 MRIguidance B.V.1 Acesion Pharma1 University of Leipzig1 Amphia Hospital1 Aarhus University Hospital Skejby1 German CLL Study Group1 QurAlis Corporation1 Diagram B.V.1 Heidelberg University1 Medical University of Graz1 Australia and New Zealand Sarcoma Association1 Dr. G.H. (Henrike) Westerveld1 Trace Neuroscience, Inc.1 Tobias Feuchtinger1 Netherlands Heart Institute1 Medical University of Vienna1 Veerle Ruijters1 Olatec Therapeutics, Inc.1 Shanghai MicroPort Medical (Group) Co., Ltd.1 Baxalta now part of Shire1 Bas P. L. Wijnhoven1 Fundacio Puigvert1 Neurosoft Bioelectronics SA1 Spark Therapeutics, Inc.1 University of Kiel1 Foundry Innovation & Research 1, Limited (FIRE1)1 IO Biotech1 Gabriel Riva1 University of Turku1 Henrik Endeman1 MeiraGTx Ocular UK Ltd1 Universitat Internacional de Catalunya1 E.S.stroes1 Dicerna Pharmaceuticals, Inc., a Novo Nordisk company1 Delcath Systems Inc.1 University of Applied Sciences Utrecht1 Elios Vision, Inc.1 Eisai Inc.1 Incyte Biosciences International Sàrl1 A.J.M. van den Eertwegh1 Cardiawave SA1 Vico Therapeutics B. V.1 The European Forum for Research and Education in Allergy and Airway Diseases1 Actelion1 Viatris Innovation GmbH1 University Hospital, Antwerp1 Tanabe Pharma America, Inc.1 Liselot Ribbert1 Savara Inc.1 OHB Neonatology Ltd.1 A.J.C. Slooter1 Prof. Jan Prins1 Eske Kvanner Aasvang1 Axonics, Inc.1 Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company1 J.P.S Henriques1 Uniquity One (UNI)1 Duke University1 Morair Medtech, LLC1 VahatiCor, Inc.1 Orthopedisch Centrum Oost Nederland1 Biotronik SE & Co. KG1 St. Olavs Hospital1 RECORDATI GROUP1 Nuvaira, Inc.1 Centre hospitalier de l'Université de Montréal (CHUM)1 Buda Health Center1 Erik de Loos1 KANDO Research1 Erasmus University Rotterdam1 EBI Anti Sepsis BV1 J.M. de Laat1 Medtronic - MITG1 Biotronik, Inc.1 J.M. ten Berg1 Shanghai MicroPort Endovascular MedTech(Group)Co., Ltd1 Turning Point Therapeutics, Inc.1 Citryll BV1 ABX advanced biochemical compounds GmbH1 Iris Plug1 Penn State University1 Marc van Sambeek1 Kyowa Kirin Pharmaceutical Development Ltd1 Bethesda Diabetes Research Center1 PDC*line Pharma SAS1 AviadoBio Ltd1 University of Virginia1 AgNovos Healthcare, LLC1 Immatics Biotechnologies GmbH1 Imbria Pharmaceuticals, Inc.1 Prof. Dr. Remi A. Nout1 Steffen Paschen1 Abraham Hulst, MD, PhD1 Jeroen Bosch Ziekenhuis1 Aziende Chimiche Riunite Angelini Francesco S.p.A1 Abby Geerlings1 GLSMED Learning Health S.A.1 NYU Langone Health1 Nick van der Beek1 Blue Earth Diagnostics1 Carmen Dietvorst1 The University of Queensland1 Taewoong Medical Co., Ltd.1 Grey Wolf Therapeutics1 C.H. van Gils1 IntraBio Inc1 Kumquat Biosciences Inc.1 CHDI Foundation, Inc.1 Matt Harmon1 St. Anna Ziekenhuis, Geldrop, Netherlands1 Universität Münster1 Heike M.U. Peulen1 Albert Schweitzer Hospital1 Maartje van den Belt1 Janssen Scientific Affairs, LLC1 Gelderse Vallei Hospital1 Nobel Biocare1 Azienda Ospedaliero-Universitaria Careggi1 Smith & Nephew, Inc.1 Stichting Reade1 Flevoziekenhuis1 Materialise1 Servier Bio-Innovation LLC1 Amber Therapeutics Ltd1 Academisch Medisch Centrum - Amsterdam UMC Research BV1 St. Anna Kinderkrebsforschung1 Aura Biosciences1 European Association of Urology Research Foundation1 Angitia Incorporated Limited1 Chalmers University of Technology1 Prometheus Biosciences, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)1 PharmaMar1 ARH van Zanten, MD PhD1 Solstice Oncology, Inc.1 Abiomed Inc.1 Rezolute1 Mark van Loo1 Mitera Hospital1 Nerviano Medical Sciences1 R.Bos1 Protagonist Therapeutics, Inc.1 Alentis Therapeutics AG1 Smith & Nephew Orthopaedics AG1 The Lowy Medical Research Institute Limited1 Sangamo Therapeutics1 POROUS GmbH1 Translumina Therapeutics Pvt Ltd.1 Göteborg University1 Shockwave Medical, Inc.1 Profound Medical Inc.1 Vedanta Biosciences, Inc.1 Institut Straumann AG1 Blue Earth Therapeutics Ltd1 ProPersona1 COMPASS Pathways1 Geron Corporation1 SecuraBio1 Penumbra Inc.1 4TEEN4 Pharmaceuticals GmbH1 Javier P. Gisbert1 Semmelweis University1 Princess Amalia Children's Clinic1 EuroBloodNet Association1 ABLE Human Motion S.L.1 Var2 Pharmaceuticals1 Uppsala University1 Wetenschappelijk Onderzoek en Datacentrum1 Van Creveldkliniek1 Essilor International1 srdpiers1 Orchard Therapeutics1 Cardiovascular Research Foundation, New York1 Fundación EPIC1 Groupe SEBBIN1 Rutger Lalieu1 Lakefront Biotherapeutics NV1 Research Maatschap Cardiologen Rotterdam Zuid1 Change Accelerator in Respiratory Care1 SymBio Pharmaceuticals1 XEOS Medical1 Marieke Duiverman1 Norgine1 M.G. Besselink1 Galderma R&D1 Cambridge University Hospitals NHS Foundation Trust1 Matthijs de Hoog1 Vivalyx GmbH1 VZW Cardiovascular Research Center Aalst1 Zydus Therapeutics Inc.1 Julius Clinical1 Morten H. Bestle1 Poitiers University Hospital1 Amsterdam University Medical Center (UMC), Location Academic Medical Center (AMC)1 Magnus Nilsson1 Therini Bio, Inc.1 Johnson & Johnson Enterprise Innovation Inc.1 113 Suicide Prevention1 ReCode Therapeutics1 POINT Biopharma, a wholly owned subsidiary of Eli Lilly and Company1 Fundación para la Investigación Biosanitaria del Principado de Asturias1 Christiaan Vinkers1 Shanghai Junshi Bioscience Co., Ltd.1 Associazione Italiana Ematologia Oncologia Pediatrica1 TransThera Sciences (Nanjing), Inc.1 AIRNA Corporation1 Centauri Therapeutics Limited1 Dentsply Sirona Implants and Consumables1 ARCAGY/ GINECO GROUP1 MoonLake Immunotherapeutics AG1 Gelre Hospitals1 Immunome, Inc.1 Science Corporation1 Exactech1 King's College Hospital NHS Trust1 Ole De Backer1 Murdoch Childrens Research Institute1 Johns Hopkins University1 Jakob Stenman1 Clinica Universidad de Navarra, Universidad de Navarra1 McMaster University1 Stichting International Registry for Alzheimer's Disease and other Dementias Foundation1 Denzel Drop1 NEAT ID Foundation1 Drahomir Aujesky1 Centre Hospitalier Universitaire de Nice1 Newcastle University1 Senz1 Ottawa Heart Institute Research Corporation1 Dijklander Ziekenhuis1 Martin Huelsmann1 Marta Marciniak1 invoX Pharma Limited1 Balt Extrusion1 AskBio Inc1 Park Medical centrum1 Idoven 1903 S.L.1 CatalYm GmbH1 UCB Biopharma SRL1 Cardurion Pharmaceuticals, Inc.1 Inhibikase Therapeutics1 Ziekenhuisgroep Twente1 Professor Monique A. H. Steegers1 Joachim Aerts, MD PhD1 Pulmonx Corporation1 Next Biomedical Co., Ltd.1 Vividion Therapeutics, Inc.1 Melanoma and Skin Cancer Trials Limited1 Idris Bahce1 Rede Optimus Hospitalar SA1 Mariette Boshuis1 AMT Medical BV1 Prof. Dr. Martin Wabitsch1 Lmito Therapeutics Inc.1 Bart Rijnders1 Rhythm Pharmaceuticals, Inc.1 GGZ Friesland1 Verve Therapeutics, Inc.1 Tristan Buck1 Milestone Pharmaceuticals Inc.1 The Leeds Teaching Hospitals NHS Trust1 dr.Frank L.J. Visseren1 Philippe ROUSSELOT1 Valérie Schuermans1 Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia1 Jos M. A. Kuijlen1 Micro Medical Solution, Inc.1 Hidde van der Ploeg1 Grifols Therapeutics LLC1 Beyond Batten Disease Foundation1 IRCCS Sacro Cuore Don Calabria di Negrar1 Mats Heyman1 Sahajanand Medical Technologies Limited1 Immatics US, Inc.1 Annexon, Inc.1 Robovision BV1 University of Calgary1 ATRO Medical B.V.1 VDyne, Inc.1 iVascular S.L.U.1 MaaT Pharma1 M. Rienstra1 CarThera1 Ellipses Pharma1 Zimmer, GmbH1 NMD Pharma A/S1 CAMP4 Therapeutics Corporation1 dr. Tom van der Hulle1 Anne Voor in 't holt1
Site location
Amsterdam1239 Rotterdam853 Groningen601 Nijmegen565 Utrecht543 Maastricht420 Leiden385 Eindhoven208 Arnhem182 Breda172 Nieuwegein149 The Hague121 's-Hertogenbosch119 Tilburg114 Zwolle109 Enschede107 Dordrecht103 Amersfoort96 Leeuwarden87 Alkmaar86 Heerlen65 Delft60 Deventer59 Apeldoorn52 Almelo51 Ede50 Almere Stad49 Hilversum42 Hoofddorp41 Harderwijk39 Veldhoven26 Beverwijk22 Haarlem22 Venlo21 Doetinchem20 Sittard-Geleen18 Amstelveen18 Emmen17 Geleen16 Wageningen16 Hengelo16 Leidschendam15 Gouda14 Helmond14 Hoorn14 Goes14 Leiderdorp13 Assen13 Roosendaal13 Sittard12 Dirksland12 Uden12 Schiedam11 Amsterdam-Zuidoost11 Geldrop10 Sneek9 Heeze9 Zutphen9 Capelle aan den IJssel8 Bergen op Zoom8 Bilthoven7 Zaandam7 Hoogeveen7 Blaricum7 Zoetermeer6 Terneuzen6 Halsteren6 Zwijndrecht5 Born5 Scheemda5 Heemstede5 Ubbergen5 Tiel5 Boxmeer4 Drachten4 Multiple Locations4 Zeist4 Boekel3 GE Rotterdam3 Roermond3 Oegstgeest3 Velp3 Heerenveen3 Brunssum2 Flushing2 Waalwijk2 Warnsveld2 Gorinchem2 Purmerend2 Oss2 Hardenberg2 Doorn2 Heerjansdam1 Mill1 Hoensbroek1 Woerden1 Eersel1 Rosmalen1 Valkenswaard1 Vlijmen1 Amsterdam, Noord-Holland1 Zuidlaren1 Balkbrug1 Goes/Vlissingen1 Deurne1 Leuven1 Friesland1 Many Locations1 Den Helder1 Heerhugowaard1 Westzeedijk 3531 Holland1 Zeeland1 Winterswijk1 Weert1 Haps1 Valkenburg1 Heemskerk1 EJ Eindhoven1 Zetten1 Ermelo1 Waalre1 Venray1 Wijk aan Zee1 Sgravenhage1 Doedrecht1 Geert Grooteplein-Zuid 81 Diemen1 HEERLENHeerlen1 Apeldoorn & Zutphen1 Eindhoven & Veldhoven1 Groningen de Brug1 Alphen aan den Rijn1 Hazerswoude-Rijndijk1 's-Gravenhage (Den Haag, the Hague)1 Beek1 Santpoort-Noord1 Maastrich1 Hoogenveen, Emmen, Stadskanaal1 Zutphens1 Baarn1 Meppel1 Beetsterzwaag1 Groesbeek1 Rotterrdam1 Etten-Leur1 Sittard Geleen1 Nederland1 Hengstdal1 Rijswijk1 Limburg1 Lochem1 IJsselstein1 Vianen1 Naarden1 Elst1 Schiphol1 Christchurch1 Lower Hutt1 Tauranga1 Wellington1 Vught1 Almere1 NL -rotterdam1
All 164 locations
Target enrolment
to

Trials in this register

3171 of 3171 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Netherlands
Start
By invitation
Robovision BV
Observational
12
Amsterdam
2025-01-24
Recruiting
Takeda
Phase 3
70
Nijmegen
2025-01-22
Active, closed
Institut de Recherches Internationales Servier
Phase 1/2
51
Rotterdam
2025-01-22
Recruiting
Endocalyx in Treatment Resistent Hypertension
NCT06940011Treatment Resistant Hypertension
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Phase 2
64
Amsterdam
2025-01-21
Recruiting
Incyte Corporation
Phase 3
240
Amsterdam, Maastricht
2025-01-21
Recruiting
[18F]ACI-19626 PET in TDP-43 Proteinopathies
NCT06891716Frontotemporal Dementia (FTD), Amyotrophic Lateral Sclerosis (ALS), TDP-43 Proteinopathies, Suspected Limbic Predominant Age-related TDP-43 Encephalopathy (LATE)
AC Immune SA
Early Phase 1
45
Amsterdam
2025-01-21
Recruiting
Deep Phenotyping of CIndU
NCT07359430Skin Diseases, Angio-Oedema and/or Urticaria
Centre for Human Drug Research, Netherlands
Observational
40
Leiden, Rotterdam, Utrecht
2025-01-21
Recruiting
Willeke Boonstra
Not applicable
318
Amsterdam
2025-01-20
Recruiting
FCV vs VCV in Obstructive and Asthmatic Patients
NCT06563544Obstructive Pulmonary Disease, Mechanical Ventilation Pressure High, Asthma COPD
Erasmus Medical Center
Not applicable
10
Rotterdam
2025-01-17
Recruiting
High Intensity Interval Training in Patients With a Right Ventricle to Pulmonary Artery Conduit
NCT06771687Congenital Heart Disease, Truncus Arteriosus, Pulmonary Atresia, Tetralogy of Fallot
Erasmus Medical Center
Not applicable
38
Nijmegen, Rotterdam
2025-01-16
Active, closed
Intellia Therapeutics
Phase 3
80
Amsterdam
2025-01-15
Active, closed
argenx
Phase 3
631
Groningen, Rotterdam
2025-01-15
Recruiting
ETOP IBCSG Partners Foundation
Phase 3
290
Amsterdam, Utrecht
2025-01-15
Recruiting
Erasmus Medical Center
Not applicable
120
Amsterdam, Leiden, Rotterdam, Utrecht
2025-01-15
Active, closed
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2
136
Maastricht
2025-01-14
Recruiting
Davy van de Sande
Observational
40
Rotterdam
2025-01-14
Recruiting
Immatics US, Inc.
Phase 3
450
Amsterdam, Groningen, Rotterdam
2025-01-14
Recruiting
The REDUCE EU Study - Endobronchial Thermal Liquid Ablation (ETLA) for the Treatment of Emphysema
NCT06655428Emphysema or COPD, Emphysema, Emphysema, Pulmonary, COPD
Morair Medtech, LLC
Not applicable
30
Groningen
2025-01-10
Active, closed
Pre-Symptomatic Detection of Impending Decompensation in Heart Failure Through Voice Data
NCT07443969Heart Failure, Chronic Heart Failure, Chronic Heart Disease
Noah Labs
Observational
123
Heerlen, Maastricht
2025-01-09
Recruiting
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Not applicable
208
Amsterdam, The Hague
2025-01-08
Recruiting
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Not applicable
60
Amsterdam-Zuidoost
2025-01-07
Recruiting
University Medical Center Groningen
Phase 1
56
Groningen
2025-01-06
Recruiting
The Impact of Metastatic Directed Radiotherapy (MDRT) on Oligoprogressive Castration Resistant Prostate Cancer (CRPC)
NCT07038304Prostate Cancer (Adenocarcinoma), OligoProgressive Metastatic Disease, Castration Resistant Metastatic Prostate Cancer, Radiotherapy
University Medical Center Groningen
Phase 2
35
Groningen, Nijmegen
2025-01-03
Recruiting
Beta-Lactam Antibiotics InitiaL ExpoSure OptimisEd in CriticallY Ill Patients with SEpsis
NCT06766461Sepsis - to Reduce Mortality in the Intensive Care Unit, Sepsis, Septic Shock
Erasmus Medical Center
Phase 4
980
Rotterdam
2025-01-03
Recruiting
Abraham Hulst, MD, PhD
Not applicable
1,008
Amsterdam
2025-01-03
Recruiting
Takeda
Phase 3
396
Amsterdam, Nijmegen, Rotterdam, Tilburg
2025-01-02
Recruiting
Italfarmaco
Phase 2
18
Leiden
2025-01-02
By invitation
Ggz Oost Brabant
Not applicable
8
Boekel
2025-01-01
Recruiting
OBESE-HFpEF: Towards Preventing Obesity Related HFpEF
NCT07539766Heart Failure and Preserved Ejection Fraction, Obesity (Disorder), Heart Failure
Zuyderland Medisch Centrum
Observational
250
Heerlen
2025-01-01
Recruiting
OveRcoming immunosupprEssion aNd rebAlancing the Immune reSponSe in ovAriaN CancEr Study
NCT06611072Ovarian Neoplasms, Ovarian Cancer, Ovarian Carcinoma, Immune Suppression
Gynaecologisch Oncologisch Centrum Zuid
Not applicable
90
Eindhoven
2025-01-01
Active, closed
ANEURYSM@RISK: Automatic Intracranial Aneurysm Quantification and Feature Learning Modelling to Optimize Intracranial Aneurysm Rupture Prediction
NCT07111975Intracranial Aneurysms, Unruptured Intracranial Aneurysm, Subarachnoid Hemorrhage (SAH) From Ruptured Aneurysm
UMC Utrecht
Observational
3,800
Utrecht
2025-01-01
Recruiting
Amsterdam UMC, location VUmc
Phase 2
25
Amsterdam
2025-01-01
Not yet open
Zuyderland Medisch Centrum
Not applicable
361
Sittard
2025-01-01
Recruiting
The Effect of ColcHicine on the Incidence of Knee or Hip Replacements
NCT06578182Osteoarthritis, Knee, Osteoarthritis, Hip
Sint Maartenskliniek
Phase 3
1,410
Nijmegen
2025-01-01
Recruiting
A Multicenter Study on Atrioventricular Regurgitation in Transthyretin Amyloid Cardiomyopathy: Definition, Prevalence, and Prognostic Impact.
NCT06836011ATTR Amyloidosis With Cardiomyopathy, ATTR-CM, ATTR Amyloidosis Wild Type, Mitral Regurgitation
Medical University of Vienna
Observational
600
Utrecht
2025-01-01
Recruiting
Neurosoft Bioelectronics SA
Not applicable
12
Utrecht
2025-01-01
Recruiting
Clinical Trial to Compare Two Surgical Approaches to the Cochlea
NCT06453343Cochlear Implants, Hearing Loss, Sensorineural
Radboud University Medical Center
Not applicable
50
Nijmegen
2025-01-01
Active, closed
Radboud University Medical Center
Phase 4
60
Nijmegen
2025-01-01
Not yet open
Automated Cardiac Arrest Detection and Alerting in Daily Life
NCT06692374Cardiac Arrest (CA), Sudden Death, Cardiac
Radboud University Medical Center
Observational
200
Nijmegen
2025-01-01
Recruiting
Urinary Tubular Biomarkers for Chronic Kidney Disease
NCT06732349Chronic Kidney Disease Stage 3
Erasmus Medical Center
Observational
556
Rotterdam
2025-01-01
Not yet open
Part of the Modern Art Study
NCT06768242HCC - Hepatocellular Carcinoma, Liver Metastases
Erasmus Medical Center
Not applicable
10
Rotterdam
2025-01
Not yet open
Quantitative Margin Assessment Using High-resolution Positron Emission Tomography - Computed Tomograhy
NCT06726512Oral Cancer, Osteosarcoma, Soft Tissue Sarcoma, Oral Squamous Cell Carcinoma (OSCC)
University Medical Center Groningen
Not applicable
30
Groningen
2025-01
Not yet open
Huntington's Disease and Pain
NCT06693466Huntington Disease, Pain
Leiden University Medical Center
Observational
20
Leiden
2025-01
Recruiting
Prevention of PostAmputation Pain With Targeted Muscle Reinnervation
NCT06719245Amputation, Surgical, Phantom Limb Pain, Neuroma Amputation, Surgery
Leiden University Medical Center
Not applicable
203
Amsterdam, Zwolle, Leiden, Leiderdorp, Rotterdam, The Hague, Utrecht
2024-12-31
Recruiting
Effect of Honey For CIN II
NCT06219018Cervical Intraepithelial Neoplasia-II, High Risk Human Papillomavirus
Zuyderland Medisch Centrum
Phase 1/2
60
Heerlen, Maastricht
2024-12-30
Recruiting
Calibration of Esophageal Balloon Catheter in Spontaneous and Mandatory Mechanical Ventilation
NCT06584604Intensive Care Unit, Mechanical Ventilation, Critical Illness
Leiden University Medical Center
Observational
40
Leiden
2024-12-29
Active, closed
RHEACELL GmbH & Co. KG
Phase 3
250
Multiple Locations
2024-12-26
Active, closed
Amgen
Phase 2
61
Amsterdam, Harderwijk, Rotterdam
2024-12-26
Recruiting
Fundación para la Investigación Biosanitaria del Principado de Asturias
Not applicable
250
Amsterdam, Breda, Eindhoven, Leiden, Maastricht, Nieuwegein, Rotterdam, Zwolle
2024-12-24
Active, closed
Nutricia Research
Observational
250
Rotterdam
2024-12-20
Active, closed
Imagery Rescripting as a Treatment for Early Psychosis
NCT06539780Psychosis, Psychotic Disorders, Schizophrenia, Psychoses, Traumatic
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Not applicable
8
Amsterdam-Zuidoost
2024-12-20
Active, closed
Vertex Pharmaceuticals Incorporated
Observational
401
Groningen, Rotterdam
2024-12-19
Recruiting
Aziende Chimiche Riunite Angelini Francesco S.p.A
Observational
200
Heeze
2024-12-19
Active, closed
argenx
Phase 3
154
Amsterdam
2024-12-18
Active, closed
Phase 2 Study of Rapcabtagene Autoleucel in Myositis
NCT06665256Idiopathic Inflammatory Myopathies
Novartis Pharmaceuticals
Phase 2
21
Amsterdam
2024-12-17
Recruiting
Erasmus Medical Center
Observational
63
Rotterdam
2024-12-17
Recruiting
Fundación EPIC
Not applicable
128
Leiden
2024-12-17
Recruiting
Chemoradiotherapy With Surgery Followed by Consolidation Durvalumab
NCT06908070Non-small Cell Lung Cancer Stage III
Idris Bahce
Phase 4
38
Amsterdam
2024-12-17
Recruiting
The Impact of Playing Tetris on Migrants' Mental Health
NCT06773338Post-traumatic Stress Disorder (PTSD), Anxiety Symptoms, Depression Symptoms
Tilburg University
Not applicable
300
The Hague
2024-12-17
Recruiting
Renal Ex Vivo Warm Advanced Resuscitation Through Machine Perfusion
NCT05782543Kidney Transplant; Complications
University Medical Center Groningen
Not applicable
240
Groningen, Leiden, Rotterdam
2024-12-15
Recruiting
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
NCT06526195Heart Failure, Heart Diseases, Cardiovascular Diseases, Pulmonary Hypertension
Abbott Medical Devices
Not applicable
850
Rotterdam, Utrecht
2024-12-13
Active, closed
GlaxoSmithKline
Phase 1/2
14
Amsterdam
2024-12-13
Recruiting
University Medical Center Groningen
Phase 4
20
Nieuwegein
2024-12-13
Recruiting
Sentinel Node and Organ-sparing Surgery in Stage I Colon Carcinoma
NCT06652672Colon Cancer, Colon Adenocarcinoma, Sentinel Lymph Node, Sentinel Lymph Node Biopsy
Meander Medical Center
Not applicable
341
Amersfoort
2024-12-12
Recruiting
Janssen Research & Development, LLC
Phase 3
700
Amersfoort, Amsterdam, Nijmegen, Rotterdam, Tilburg
2024-12-12
Active, closed
AstraZeneca
Phase 2
24
Amsterdam, Nijmegen
2024-12-11
Active, closed
Study to Evaluate Ultevursen in Subjects With Retinitis Pigmentosa (RP) Due to Mutations in Exon 13 of the USH2A Gene
NCT06627179Retinitis Pigmentosa (RP), Usher Syndrome Type 2, Deaf Blind, Retinal Disease
Laboratoires Thea
Phase 2
81
Amsterdam, Nijmegen, Rotterdam
2024-12-11
Active, closed
Hoffmann-La Roche
Phase 3
350
Tilburg
2024-12-11
Recruiting
PET-imaging of Two Vartumabs in Patients With Solid Tumors
NCT06645808Solid Tumor, Colon Carcinoma, Rectal Carcinoma, Osteosarcoma
Var2 Pharmaceuticals
Early Phase 1
32
Groningen
2024-12-10
Recruiting
Novartis Pharmaceuticals
Phase 3
60
Amsterdam
2024-12-09
Active, closed
Amgen
Phase 3
707
Amsterdam, Delft, Groningen, Nijmegen, Rotterdam
2024-12-09
Active, closed
Kumquat Biosciences Inc.
Phase 1
13
Nijmegen
2024-12-09
Recruiting
Jord Vink
Not applicable
454
's-Hertogenbosch, Amsterdam, Beetsterzwaag, Breda, Doorn, Eindhoven, Groesbeek, Hilversum
2024-12-09
Recruiting
QUALAS Validation in Dutch
NCT06723951Spina Bifida
Erasmus Medical Center
Observational
300
Groningen, Rotterdam
2024-12-09
Recruiting
Maastricht University Medical Center
Not applicable
32
Maastricht
2024-12-09
By invitation
Phase 1b Long-term Extension Trial of RAY121 in Immunological Diseases (RAINBOW-LTE Trial)
NCT06723106Antiphospholipid Syndrome (APS), Bullous Pemphigoid (BP), Behçet's Syndrome (BS), Dermatomyositis (DM)
DrugRAY121
Chugai Pharmaceutical
Phase 1
144
Groningen, Utrecht
2024-12-09
Recruiting
Johnson & Johnson Enterprise Innovation Inc.
Phase 2
130
Amsterdam, Nijmegen
2024-12-06
Recruiting
Effects of Wild Blueberry Consumption on Brain Function in Elderly
NCT07177781Brain Insulin-sensitivity, Brain Vascular Function, Cerebral Blood Flow
Maastricht University Medical Center
Not applicable
36
Maastricht
2024-12-05
Active, closed
Janssen Research & Development, LLC
Phase 3
655
Enschede
2024-12-04
Recruiting
The Value of Near-infrared Spectroscopy and Blood Pressure Measurements in Estimating Future Fall Risk in Older Adults
NCT06714565Falls, Orthostatic Hypotension, Older Adults (65 Years and Older)
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Observational
141
Amsterdam
2024-12-04
Active, closed
Leiden University Medical Center
Not applicable
60
Leiden
2024-12-04
Recruiting
Janssen Research & Development, LLC
Phase 1
276
Amsterdam, Groningen, Utrecht
2024-12-04
Recruiting
Institut de Recherches Internationales Servier
Phase 3
48
Amsterdam, Groningen
2024-12-03
Recruiting
OSE Immunotherapeutics
Phase 3
363
Nijmegen, Rotterdam, Groningen
2024-12-03
Recruiting
Artificial Intelligence in ANOCA
NCT06387693Angina, Stable
UMC Utrecht
Not applicable
250
Utrecht
2024-12-03
Recruiting
PPI and Mindfulness App for Parents of Children with a NDD
NCT06248762Stress, Mental Health, Mental Well-being
University of Twente
Not applicable
212
Enschede
2024-12-03
By invitation
A Study to Evaluate Vutrisiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
NCT06679946Transthyretin Amyloidosis (ATTR) With Cardiomyopathy
Alnylam Pharmaceuticals
Phase 3
700
Groningen, Maastricht, Utrecht
2024-12-03
Recruiting
The Effects of a Dynamic Arm Support in Daily Life
NCT07121075Neuromuscular Disease, Neuromuscular Disability, Assistive Technology, Activities of Daily Living
Hasselt University
Observational
50
Tilburg
2024-12-02
Recruiting
Erasmus Medical Center
Observational
200
Rotterdam
2024-12-02
Recruiting
Merck Sharp & Dohme LLC
Phase 3
3,082
2024-12-02
Not yet open
Growing up With the Young Endocrine Support System (YESS!)
NCT04252001Congenital Adrenal Hyperplasia, Hypogonadotropic Hypogonadism, Growth Hormone Deficiency, Combined Pituitary Hormone Deficiency
dr. Laura C. G. de Graaff-Herder
Not applicable
160
Rotterdam
2024-12-01
Recruiting
Reference Values for the Muscle Power Sprint Test
NCT06448520Development, Child, Activity, Motor
Erasmus Medical Center
Not applicable
480
Rotterdam
2024-12-01
Recruiting
Amsterdam UMC, location VUmc
Not applicable
34
Amsterdam
2024-12-01
Recruiting
Improving Chronic Nocturnal Noninvasive Ventilation: a Multimodality Approach
NCT05756387Chronic Respiratory Failure, Non-invasive Ventilation
University Medical Center Groningen
Observational
100
Groningen
2024-12-01
By invitation
Hidde van der Ploeg
Not applicable
100
Utrecht
2024-12-01
Recruiting
Amsterdam UMC
Not applicable
15
Amsterdam
2024-12
Recruiting
Mara Veenstra, MD
Phase 2/3
81
Amsterdam, Rotterdam, Utrecht
2024-11-29
Recruiting
Avapritinib Rollover Study
NCT06748001Mastocytosis, Systemic
Blueprint Medicines Corporation
Phase 4
60
Groningen, Rotterdam
2024-11-28
Active, closed
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Observational
94
Amsterdam, Leiden
2024-11-28
Recruiting
AstraZeneca
Phase 3
1,160
Alkmaar, Ede, Groningen, Leidschendam, Veldhoven
2024-11-27
Recruiting
Restrictive Versus Liberal Thresholds for RBC Transfusion in ECMO
NCT06560164Transfusion, Red Blood Cell, Extracorporeal Membrane Oxygenation, Anemia
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Not applicable
526
Enschede, Nijmegen, Maastricht, Amsterdam, Groningen, Leiden, Rotterdam, Nieuwegein
2024-11-26
Active, closed
AbbVie
Observational
1,314
Apeldoorn, Veldhoven, Zaandam, Zwolle, Rotterdam
2024-11-26
Active, closed
Genmab
Phase 3
191
Amsterdam, Harderwijk, Heerlen, Leiden, Nijmegen, Rotterdam, Utrecht, Zwolle
2024-11-25
Recruiting
Asylumseekers Experiencing Paranoid Delusions: A Virtual Reality Study
NCT06692530Schizophrenia Disorders, Paranoid Delusions
University Medical Center Groningen
Observational
15
Balkbrug
2024-11-22
Recruiting
Washington University School of Medicine
Phase 2/3
280
Amsterdam
2024-11-22
Recruiting
Washington University School of Medicine
Phase 2/3
280
Amsterdam
2024-11-22
Active, closed
Vertex Pharmaceuticals Incorporated
Phase 3
50
Rotterdam
2024-11-21
Recruiting
First-Line Intervention for PTSD - Intensive Treatment
NCT06700590PTSD - Post Traumatic Stress Disorder
ARQ National Psychotrauma Centre
Not applicable
186
Diemen, Haarlem, Groningen, Oegstgeest
2024-11-21
Recruiting
Forearm Immobilization in T2D
NCT06750497Healthy, Type 2 Diabetes
Wageningen University
Not applicable
26
Wageningen
2024-11-21
Recruiting
The Netherlands Cancer Institute
Phase 3
306
Amsterdam
2024-11-21
Recruiting
UCB Biopharma SRL
Phase 3
450
Amsterdam, Groningen, Maastricht
2024-11-21
Not yet open
Early Artificial Lateral Prosthesis
NCT06705985Post-Meniscectomy Pain Syndrome
ATRO Medical B.V.
Not applicable
16
Nijmegen
2024-11-21
Recruiting
Additional Chemotherapy Administered Directly Into the Liver Using a Chemo Pump in Patients With Bile Duct Cancer Inside the Liver Treatable by Surgery
NCT06888063Intrahepatic Bile Duct Cancer, Intrahepatic Cholangiocarcinoma (Icc), Intrahepatic Bile Duct Carcinoma, Intrahepatic Cholangiocarcinoma
Erasmus Medical Center
Phase 2
40
Rotterdam
2024-11-20
Recruiting
COgnitive Dynamics in Early Childhood
NCT06330090Cognitive Change
Radboud University Medical Center
Observational
600
Nijmegen
2024-11-18
Recruiting
AstraZeneca
Phase 3
1,160
Alkmaar, Ede, Groningen, Leidschendam, Veldhoven, Zwolle
2024-11-18
Recruiting
Sahlgrenska University Hospital
Not applicable
50
Arnhem
2024-11-15
Recruiting
Christiaan Vinkers
Phase 2
60
Amsterdam
2024-11-15
Recruiting
Maastricht University Medical Center
Not applicable
64
Maastricht
2024-11-14
Recruiting
Daiichi Sankyo
Phase 1
150
Amsterdam
2024-11-14
Recruiting
Methylphenidate in KBG Syndrome: N-of-1 Series
NCT06465641Kbg Syndrome, ADHD - Combined Type
Radboud University Medical Center
Phase 4
15
Nijmegen
2024-11-13
Active, closed
Radboud University Medical Center
Not applicable
256
Nijmegen
2024-11-12
Recruiting
Boehringer Ingelheim
Phase 3
1,590
Dordrecht, Rotterdam, Schiedam
2024-11-12
Recruiting
Zealand Pharma
Phase 1
124
Leiden
2024-11-12
Recruiting
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3
290
Leiden, Rotterdam
2024-11-11
Active, closed
Longboard Pharmaceuticals
Phase 3
367
Utrecht
2024-11-11
By invitation
Radboud University Medical Center
Phase 2/3
100
Eindhoven, Rotterdam, Nijmegen, Utrecht
2024-11-11
Recruiting
C.H. van Gils
Not applicable
36,000
Utrecht
2024-11-11
Active, closed
argenx
Phase 2
87
Leiden
2024-11-11
Recruiting
Leiden University Medical Center
Phase 4
10,078
Apeldoorn, Geleen, Geldrop, Tilburg, Amsterdam, Naarden, Zwolle, Leiderdorp
2024-11-11
Active, closed
Santhera Pharmaceuticals
Phase 4
80
Leiden, Nijmegen
2024-11-10
Recruiting
Fluorescence Imaging of Risankizumab-800CW in Inflammatory Bowel Disease
NCT06606808Ulcerative Colitis (UC), Crohn Disease (CD)
University Medical Center Groningen
Phase 1/2
18
Groningen
2024-11-08
Recruiting
University Medical Center Groningen
Phase 1/2
12
Groningen
2024-11-06
Recruiting
The Effectiveness of a Dutch Program in Preventing Criminal Exploitation
NCT07157761Delinquency, Externalizing Behavior
Utrecht University
Not applicable
200
Utrecht
2024-11-05
By invitation
10-year Follow-up of the Ponto Wide-implant
NCT06772714Survival of the Ponto Wide Implant
University Medical Center Nijmegen
Observational
64
Nijmegen
2024-11-04
Recruiting
Glycogen Storage Disease Type Ia (GSDIa) Disease Monitoring Program
NCT06636383Glycogen Storage Disease Type Ia
Ultragenyx Pharmaceutical Inc
Observational
140
Groningen
2024-11-04
Recruiting
Haaglanden Medical Centre
Phase 2
128
The Hague
2024-11-04
Recruiting
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Observational
300
Almere Stad, Amsterdam, Eindhoven, Zwolle
2024-11-01
Active, closed
RELIEF-pathway in Patients With Upper Abdominal Pain
NCT06002516Abdominal Pain, Gallstone; Colic, Dyspepsia, Irritable Bowel Syndrome
Radboud University Medical Center
Not applicable
471
Nijmegen
2024-11-01
Recruiting
P4O2 ILD Extension
NCT06644144Interstitial Lung Disease, Pulmonary Fibrosis, Interstitial Lung Fibrosis, IPF
Amsterdam UMC, location VUmc
Observational
450
Amsterdam
2024-11-01
Not yet open
Long-term Ophthalmic Outcomes in Ex-premature Infants
NCT06649513Retinopathy of Prematurity (ROP), Premature Birth
Erasmus Medical Center
Observational
210
Rotterdam
2024-11-01
Recruiting
JL Tol
Phase 3
50
Amsterdam
2024-10-30
Recruiting
Abivax S.A.
Phase 2
212
Amsterdam, Maastricht, Nijmegen, Tilburg, Uden
2024-10-30
Recruiting
Phase 1b Study of VERVE-201 in Patients With Refractory Hyperlipidemia
NCT06451770Hypercholesterolemia, Hypertriglyceridemia, Refractory Hyperlipidemia
Verve Therapeutics, Inc.
Phase 1
132
Amsterdam, Rotterdam
2024-10-30
Active, closed
Novartis Pharmaceuticals
Phase 2
96
Utrecht
2024-10-29
Active, closed
A Study of Mosliciguat in PH-ILD
NCT06635850Pulmonary Hypertension, Interstitial Lung Disease, Lung Diseases, Vascular Diseases
Pulmovant, Inc.
Phase 2
135
Nijmegen, Amsterdam
2024-10-29
Recruiting
Royal Dutch Visio
Not applicable
60
Nijmegen
2024-10-25
Recruiting
Pierre Fabre Medicament
Phase 1/2
140
Amsterdam
2024-10-22
Recruiting
Pfizer
Phase 3
900
Nijmegen, Amsterdam, Leeuwarden, Schiedam
2024-10-22
Recruiting
Wageningen University
Not applicable
40
Arnhem, Ede
2024-10-22
Recruiting
Koen Munters
Phase 4
148
Apeldoorn, Arnhem, Nieuwegein
2024-10-21
Recruiting
Radboud University Medical Center
Phase 3
854
Nijmegen
2024-10-21
Recruiting
Arkin
Not applicable
358
Halsteren, Helmond, Amsterdam, Almelo, Zeist
2024-10-21
Recruiting
Merck Sharp & Dohme LLC
Phase 3
680
Nijmegen, Maastricht, 's-Hertogenbosch, Leeuwarden, Amersfoort, Groningen
2024-10-21
Active, closed
Pfizer
Phase 3
609
Nijmegen, Hilversum, Leeuwarden, Amersfoort
2024-10-21
Active, closed
Novartis Pharmaceuticals
Phase 2
251
Utrecht
2024-10-17
Active, closed
Uniquity One (UNI)
Phase 2
184
Maastricht, Rotterdam
2024-10-16
Recruiting
Amsterdam University Medical Center (UMC), Location Academic Medical Center (AMC)
Phase 3
100
Amsterdam
2024-10-16
Recruiting
Study of ATX-01 in Participants With DM1
NCT06300307Myotonic Dystrophy 1
ARTHEx Biotech S.L.
Phase 1/2
56
Nijmegen
2024-10-15
Recruiting
Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers
NCT06562192Pancreatic Ductal Adenocarcinoma, Non-small Cell Lung Cancer, HR+/HER2- Ductal and Lobular Breast Cancer, Triple Negative Breast Cancer
Novartis Pharmaceuticals
Phase 1
162
Nijmegen, Utrecht
2024-10-15
Not yet open
Amsterdam UMC, location VUmc
Observational
600
Arnhem, Geleen, Amsterdam
2024-10-15
Recruiting
Atrial Fibrillation Network
Not applicable
2,312
Multiple Locations
2024-10-14
Recruiting
Amniotic Fluid & the Preterm Gut
NCT07152106Chorioamnionitis, Chorioamnionitis Affecting Fetus or Newborn, Necrotizing Enterocolitis of Newborn, Neonatal Sepsis, Early-Onset
Maxima Medical Center
Observational
275
Amsterdam, Veldhoven
2024-10-14
Recruiting
Boehringer Ingelheim
Phase 3
1,800
Amsterdam, Dordrecht, Nijmegen, Rotterdam, Schiedam, Tilburg
2024-10-14
Recruiting
Jord Vink
Not applicable
40
Utrecht
2024-10-11
Recruiting
Boehringer Ingelheim
Phase 2
588
Amsterdam, Nijmegen
2024-10-11
Active, closed
Incyte Corporation
Phase 3
349
Amsterdam, Veldhoven
2024-10-10
Recruiting
InvaplexAR-Detox and DmLT Adjuvant in the Netherlands and Zambia
NCT05961059Shigellosis, Bacillary Dysentery
Leiden University Medical Center
Phase 1
85
Leiden
2024-10-10
Recruiting
JointResearch
Observational
51
Amsterdam
2024-10-10
Recruiting
Cycling Through the Menstrual Cycle
NCT06634134Menstrual Cycle-based Periodized Training, Female Athlete Triad, Menstrual Cycle
Martini Hospital Groningen
Observational
750
Groningen
2024-10-10
Active, closed
SynOx Therapeutics Limited
Phase 3
128
Leiden
2024-10-09
Recruiting
Annemie Spooren
Not applicable
44
Hoensbroek
2024-10-09
Active, closed
nCLE-Cone-beam CT Navigation Bronchoscopy
NCT06505642Lung Neoplasm, Peripheral Lung Parenchyma Tumor, Lung Cancer
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Not applicable
25
Amsterdam
2024-10-08
Active, closed
Novartis Pharmaceuticals
Phase 1
54
Leiden
2024-10-08
Recruiting
UMC Utrecht
Not applicable
140
Utrecht
2024-10-08
Active, closed
Enhancement of Quality of Work And Life
NCT06573866Parkinson Disease, Hereditary Spastic Paraparesis, Cerebellar Ataxia, Mitochondrial Diseases
Radboud University Medical Center
Not applicable
124
Nijmegen
2024-10-08
Recruiting
Bristol-Myers Squibb
Phase 3
1,000
Harderwijk, Heerlen, 's-Hertogenbosch, Zwolle, Leiden, The Hague, Arnhem, Groningen
2024-10-07
Active, closed
BIO|MASTER.CSP Study
NCT06620237Cardiac Pacing, Artificial, Cardiac Pacemaker, Artificial, Cardiac Resynchronization Therapy Devices, Bradycardia
Biotronik SE & Co. KG
Not applicable
152
Alkmaar, Eindhoven
2024-10-04
Recruiting
Pain in Endometriosis And the Relation to Lifestyle
NCT06332560Endometriosis, Adenomyosis
Radboud University Medical Center
Not applicable
250
's-Hertogenbosch, Arnhem, Breda, Eindhoven, Nijmegen
2024-10-04
Recruiting
Rhu-pGSN for Acute Respiratory Distress Syndrome (ARDS)
NCT05947955Acute Respiratory Distress Syndrome, Infections
BioAegis Therapeutics Inc.
Phase 2
600
's-Hertogenbosch, Apeldoorn, Ede, Enschede, Nijmegen
2024-10-03
Recruiting
Frequency of Interrupting Sitting and Cognitive Function
NCT06700187Sedentary Behaviors, Breaking Prolonged Sitting With Physical Activity
Maastricht University Medical Center
Not applicable
33
Maastricht
2024-10-03
Recruiting
REDucing Hot FLASHes in Women Using Endocrine Therapy.
NCT06106529Breast Cancer, Hot Flash Due to Medication
Reinier de Graaf Groep
Phase 3
260
Delft
2024-10-03
Recruiting
Screening for Malnutrition in Obese Patients
NCT06626360Overweight and Obese Adults, Malnutrition or Risk of Malnutrition
HAN University of Applied Sciences
Observational
2,000
Amsterdam, Ede, Rotterdam
2024-10-02
Recruiting
Erasmus Medical Center
Not applicable
30
Rotterdam
2024-10-02
Recruiting
Implementation of Home Monitoring in Patients With Pulmonary Fibrosis
NCT06883448Pulmonary Fibrosis, Interstitial Lung Disease (ILD)
Erasmus Medical Center
Not applicable
220
Amsterdam, Arnhem, Breda, Eindhoven, Heerlen, Leeuwarden, Leiden, Nieuwegein
2024-10-02
Recruiting
Preoperative Prehabilitation in Patients Planned for Liver Transplantation
NCT06808945Liver Transplant; Complications, Physical Inactivity
Erasmus Medical Center
Not applicable
60
Rotterdam
2024-10-02
By invitation
University Medical Center Groningen
Observational
50
Groningen
2024-10-01
Recruiting
University Medical Center Groningen
Observational
15
Groningen
2024-10-01
Not yet open
University Medical Center Groningen
Not applicable
50
Groningen
2024-10-01
Recruiting
University Hospital, Geneva
Not applicable
220
Maastricht
2024-10-01
Active, closed
Stemline Therapeutics, Inc.
Phase 3
4,556
Tilburg, Dordrecht, The Hague, Eindhoven
2024-09-27
Active, closed
BioCryst Pharmaceuticals
Phase 1
76
Maastricht, Rotterdam
2024-09-26
Active, closed
Boehringer Ingelheim
Phase 3
1,666
HEERLENHeerlen, Leiden, Nieuwegein, Rotterdam
2024-09-26
Active, closed
Genmab
Phase 3
699
Amsterdam, Nijmegen, Utrecht
2024-09-25
Active, closed
Hoffmann-La Roche
Phase 3
338
's-Hertogenbosch, Arnhem, Breda, Harderwijk, Leidschendam, Zwolle
2024-09-23
Recruiting
Neoadjuvant Triple Therapy for (Borderline) Resectable Pancreatic Cancer (PREOPANC-5)
NCT06384560Localized Pancreatic Adenocarcinoma, Borderline Resectable Pancreatic Adenocarcinoma, Resectable Pancreatic Adenocarcinoma
Amsterdam UMC, location VUmc
Phase 1/2
66
Amsterdam, Maastricht, Nieuwegein, Rotterdam
2024-09-23
Recruiting
Presepsin to Safely Reduce Antibiotics in Preterm Infants
NCT06100614Early-Onset Neonatal Sepsis
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Not applicable
900
Amsterdam
2024-09-23
Recruiting
University Medical Center Groningen
Not applicable
154
Groningen
2024-09-20
Recruiting
Effect of EMDR for Reduction of Pain Interference in Children With Sickle Cell Disease
NCT07001631Sickle Cell Disease, Pain, Pain, Chronic Disease
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Not applicable
40
Amsterdam
2024-09-20
Recruiting
Janssen Research & Development, LLC
Phase 2/3
274
Nijmegen, Rotterdam
2024-09-19
Active, closed
argenx
Phase 3
141
Leiden
2024-09-18
Recruiting
Pierre Fabre Medicament
Phase 1/2
171
Amsterdam
2024-09-17
Active, closed
Dianthus Therapeutics
Phase 2
46
Amsterdam, Utrecht
2024-09-17
Recruiting
European Registry of Next Generation Imaging in Advanced Prostate Cancer
NCT06866782Prostate Cancer, Advanced Prostate Cancer, Metastatic Prostate Cancer (mPC)
Fundacio Puigvert
Observational
600
Rotterdam
2024-09-17
Recruiting
Psychoeducation for Older Adults With Autism
NCT06127472Autism Spectrum Disorder
Tilburg University
Not applicable
120
Apeldoorn, Heerlen, Venray, 's-Hertogenbosch, Eindhoven, Halsteren, Tilburg, Hoorn
2024-09-12
Recruiting
GlaxoSmithKline
Phase 3
440
Maastricht, Rotterdam, Utrecht
2024-09-11
Recruiting
Left Bundle Branch Area Pacing or Biventricular Pacing in AF and Left Ventricular Dysfunction
NCT06620705Heart Failure, Block, Heart, Pacing-Induced Cardiomyopathy
srdpiers
Not applicable
34
Leiden
2024-09-10
Recruiting
Improved Prescribing for Older Nursing Home Patients
NCT06731361Nursing Home Residents, Older People, Prescribing, Advance Care Planning
Amsterdam UMC, location VUmc
Not applicable
450
Apeldoorn, Harderwijk, Amsterdam, Hilversum, IJsselstein, Vianen, Groningen
2024-09-10
Active, closed
Evaluation of the Effect of Lomitapide Treatment on Major Adverse Cardiovascular Events (MACE) in Patients With Homozygous Familial Hypercholesterolemia
NCT06832371Homozygous Familial Hypercholesterolemia (HoFH), Major Adverse Cardiovascular Events (MACE), Dyslipidemia
Fondazione SISA (Societa Italiana per lo Studio della Arteriosclerosi)
Observational
73
Nijmegen, Rotterdam
2024-09-09
Recruiting
Lakefront Biotherapeutics NV
Phase 3
546
Amsterdam, Leiden, Rotterdam
2024-09-09
Recruiting
Australia and New Zealand Sarcoma Association
Observational
100
Amsterdam
2024-09-05
Recruiting
University of Kiel
Not applicable
60
Amsterdam
2024-09-05
Recruiting
STIMPulseControl Ancillary Speech Study
NCT06561919Parkinson Disease, Impulse Control Disorder
Steffen Paschen
Not applicable
60
Amsterdam
2024-09-05
Recruiting
AbbVie
Phase 2
590
Tilburg, Amsterdam, Groningen, Utrecht
2024-09-04
Active, closed
Novartis Pharmaceuticals
Phase 2
179
Groningen, Leiden, Utrecht
2024-09-04
Recruiting
Gossamer Bio USA, Inc.
Phase 3
330
Amsterdam, Rotterdam
2024-09-03
Active, closed
Novo Nordisk A/S
Phase 1
63
Groningen
2024-09-03
Recruiting
Preoperative Optimisation of Modifiable Risk Factors in Surgery of the Pancreas
NCT05851534Prehabilitation, Pancreas Cancer, Surgery, Postoperative Complications
Maastricht University Medical Center
Not applicable
2,575
's-Hertogenbosch, Amsterdam, Breda, Eindhoven, Enschede, Groningen, Leeuwarden, Leiden
2024-09-02
Recruiting
VieCuri Medical Centre
Not applicable
170
Venlo, Geldrop
2024-09-01
By invitation
Primary Posterior Tracheopexy Prevents Tracheal Collapse
NCT06335862Oesophageal Atresia With Tracheo-Oesophageal Fistula, Tracheomalacia, Oesophageal Atresia
UMC Utrecht
Not applicable
78
Rotterdam, Utrecht
2024-09-01
By invitation
B-challenged: Co-creating Physical and Social Environments to Promote Children's Active Outdoor Play
NCT07136376Active Outdoor Play and Related Healthy Dietary Behaviours
Amsterdam UMC, location VUmc
Not applicable
850
Amsterdam
2024-09-01
Active, closed
Erasmus Medical Center
Not applicable
1,786
Rotterdam
2024-09-01
Recruiting
CRS Questionnaire Validation Project
NCT06970977Chronic Rhinosinusitis (CRS) With and Without Nasal Polyps
The European Forum for Research and Education in Allergy and Airway Diseases
Observational
1,000
Amsterdam, Leiden
2024-09-01
Recruiting
Wageningen University
Not applicable
102
Arnhem, Ede
2024-09-01
Recruiting
Ten Year Follow-up in FSHD: the FOCUS 3 Study
NCT06911190FSHD - Facioscapulohumeral Muscular Dystrophy
Radboud University Medical Center
Observational
200
Nijmegen
2024-09-01
Active, closed
Ventilator Settings and Outcomes in Pediatric Patients on ECMO for Severe Respiratory Failure
NCT06899009Critical Illness, Respiratory Failure (Pediatric Patients)
University Medical Center Groningen
Observational
750
Groningen
2024-09-01
Active, closed
Alpine Immune Sciences Inc, A Subsidiary of Vertex
Phase 3
605
Groningen, Nijmegen
2024-08-30
Active, closed
Sanofi
Phase 2
229
Amsterdam, Arnhem
2024-08-29
Recruiting
HIP-STITCH (Wound Recovery After THA)
NCT06275776Wound Healing Disturbance of
Reinier Haga Orthopedisch Centrum
Not applicable
236
Zoetermeer
2024-08-28
Active, closed
Phase IIa Study Evaluating AZD7798 in Crohn's Disease
NCT06450197Moderate to Severe Crohn's Disease
AstraZeneca
Phase 2
120
Amsterdam
2024-08-28
Recruiting
OPTImizing CArdiac REhabilitation by REfining Sleep and STress
NCT06505109Cardiovascular Diseases, Cardiac Rehabilitation
Erasmus Medical Center
Not applicable
200
Eindhoven, Rotterdam, The Hague
2024-08-28
Recruiting
Prevail Therapeutics
Phase 1
124
Nijmegen, Groningen
2024-08-27
Active, closed
Feasibility of the Maastro Applicator in Rectal Cancer
NCT06087718Rectal Cancer, Feasibility, Toxicity, Quality of Life
Maastricht Radiation Oncology
Not applicable
10
Maastricht
2024-08-27
Active, closed
Viridian Therapeutics, Inc.
Phase 3
204
Amsterdam, Rotterdam
2024-08-27
Active, closed
Viridian Therapeutics, Inc.
Phase 3
132
Amsterdam, Rotterdam
2024-08-27
Recruiting
Janssen Research & Development, LLC
Phase 2
210
Amsterdam, Dordrecht, Rotterdam
2024-08-26
Active, closed
Kite, A Gilead Company
Phase 3
452
Amsterdam, Groningen, Rotterdam
2024-08-23
By invitation
EMDR for Persistent Pain in RA
NCT05941559Rheumatoid Arthritis
Medisch Spectrum Twente
Not applicable
10
Enschede
2024-08-22
Recruiting
COLDFIRE-III Trial: Efficacy of Irreversible Electroporation and Stereotactic Body Radiotherapy for Perivascular and Peribiliary Colorectal Liver Metastases
NCT06185556Colorectal Cancer, Liver Metastases, Liver Metastasis Colon Cancer, Unresectable Solid Tumor
Amsterdam UMC, location VUmc
Phase 2/3
78
Amsterdam
2024-08-20
Recruiting
Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)
NCT06371417Antiphospholipid Syndrome (APS), Bullous Pemphigoid (BP), Behçet's Syndrome (BS), Dermatomyositis (DM)
DrugRAY121
Chugai Pharmaceutical
Phase 1
144
Groningen, Utrecht
2024-08-19
Recruiting
Erasmus Medical Center
Observational
250
Rotterdam
2024-08-19
Recruiting
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
NCT06395103B-cell Acute Lymphoblastic Leukemia, Diffuse Large B-cell Lymphoma, Burkitt Lymphoma, Neuroblastoma
Merck Sharp & Dohme LLC
Phase 1/2
90
Utrecht
2024-08-16
Recruiting
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 3
324
's-Hertogenbosch, Almelo, Amstelveen, Apeldoorn, Arnhem, Breda, Delft, Dordrecht
2024-08-15
Recruiting
Amsterdam University of Applied Sciences
Not applicable
200
Amsterdam
2024-08-13
Recruiting
An Extension Study for Patients Previously Enrolled in Studies With Pelabresib
NCT06401356Hematologic Malignancy, Solid Tumor, Advanced Malignancies
Novartis Pharmaceuticals
Phase 3
50
Amsterdam
2024-08-13
Recruiting
Carboplatin/Paclitaxel + Pembrolizumab for Locoregionally Advanced Penile Cancer
NCT06353906Urologic Neoplasms, Urogenital Neoplasms, Male Urogenital Diseases, Penile Cancer
The Netherlands Cancer Institute
Phase 2
27
Amsterdam
2024-08-13
Recruiting
Iron Infusion in Patients Undergoing Transcatheter Aortic Valve Implantation
NCT07370688Aortic Valve Stenosis, Iron Deficiency, TAVI(Transcatheter Aortic Valve Implantation), Cardiovascular Diseases
Erasmus Medical Center
Phase 4
402
Rotterdam
2024-08-12
Active, closed
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Not applicable
18
Amsterdam
2024-08-09
Recruiting
Feasibility of Primer Shot Radiotherapy for Non-small Cell Lung Cancer - PRIMER
NCT06528743Patients With Non-small-cell Lung Cancer
The Netherlands Cancer Institute
Not applicable
34
Amsterdam
2024-08-08
Recruiting
VECTORS - A Study to Evaluate Transmural Healing as a Treatment Target in Crohn's Disease
NCT06257706Moderately to Severely Active Crohn's Disease, Crohn Disease, Disease Crohn
Alimentiv Inc.
Phase 4
304
Nijmegen, Amsterdam, Rotterdam, Tilburg
2024-08-07
Recruiting
Spinal Cord Monitoring in Multiple Sclerosis
NCT06827834Multiple Sclerosis
Zuyderland Medisch Centrum
Observational
155
Arnhem, Geleen, 's-Hertogenbosch, Dordrecht, Rotterdam
2024-08-06
Recruiting
Boehringer Ingelheim
Phase 1
12
Amsterdam
2024-08-06
Recruiting
Fluorescence Imaging of IBD and RA Using Adalimumab-800CW
NCT03938701IBD, Rheumatoid Arthritis
DrugHumira
University Medical Center Groningen
Phase 2
36
Groningen
2024-08-06
Active, closed
Merck Sharp & Dohme LLC
Phase 3
3,000
Nijmegen, Amsterdam, Hoorn, Utrecht
2024-08-05
Recruiting
FAPI Molecular Imaging for Diagnosis of the CMS4 Unfavorable Colorectal Cancer Subtype
NCT06191120Metastatic Colorectal Cancer, Metastatic Cancer to Liver
UMC Utrecht
Not applicable
45
Utrecht
2024-08-05
Recruiting
General Practitioners Research Institute
Not applicable
900
Groningen
2024-08-05
Active, closed
XVIVO Perfusion
Not applicable
40
Groningen, Rotterdam, Utrecht
2024-08-03
Recruiting
Targeted Pediatric High-Grade Glioma Therapy
NCT05839379High Grade Glioma, Diffuse Intrinsic Pontine Glioma, Anaplastic Astrocytoma, Glioblastoma
Nationwide Children's Hospital
Observational
350
Utrecht
2024-08-02
Recruiting
MB-dNPM1-TCR.1 in Relapsed/Refractory AML
NCT06424340Leukemia, Myeloid, Acute
Miltenyi Biomedicine GmbH
Phase 1/2
29
Leiden
2024-08-01
Not yet open
FET-PET-Guided Management of Pseudoprogression in Glioblastoma
NCT06480721Glioblastoma, Radionecrosis of Brain
Veerle Ruijters
Not applicable
144
Amsterdam, Enschede, Groningen, Maastricht, Nijmegen, Rotterdam, The Hague, Utrecht
2024-08
Recruiting
University Medical Center Groningen
Phase 3
300
Amsterdam, Groningen, Rotterdam
2024-07-31
Recruiting
CellFX® nsPFA™ Cardiac Surgery System to Treat Atrial Fibrillation
NCT06355063Atrial Fibrillation, Surgery, Ablation of Atrial Fibrillation, Clamp Study
Pulse Biosciences, Inc.
Not applicable
30
Amsterdam, Eindhoven, Maastricht, Nieuwegein
2024-07-31
Recruiting
NovoCure GmbH
Phase 3
734
Arnhem, Friesland, Harderwijk, Utrecht
2024-07-31
Active, closed
Astellas Pharma Global Development, Inc.
Phase 3
982
Breda, Dirksland, Haarlem, Rotterdam, Terneuzen
2024-07-31
By invitation
Biohaven Therapeutics Ltd.
Phase 2
660
Heeze, Heemstede, Zwolle
2024-07-30
Recruiting
The OPTIMISE Study
NCT05716945Pseudophakic Bullous Keratopathy, Fuchs' Endothelial Dystrophy, Intraocular Pressure
Maastricht University Medical Center
Phase 4
342
Apeldoorn, Nijmegen, Maastricht, Amsterdam, Deventer, Groningen, Leiden, Utrecht
2024-07-29
Active, closed
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 2
25
Amsterdam, Groningen, Rotterdam
2024-07-26
Recruiting
UMC Utrecht
Phase 1
24
Utrecht
2024-07-26
Recruiting
University Medical Center Groningen
Not applicable
604
Groningen
2024-07-25
Recruiting
Universität Münster
Observational
257
Nijmegen
2024-07-24
Recruiting
PulseSelect™ PFA Global Registry
NCT06393920Atrial Fibrillation
Medtronic Cardiac Ablation Solutions
Observational
1,950
Nieuwegein
2024-07-23
Active, closed
DUTCH Weight Control in Atrial Fibrillation Study
NCT06184633Atrial Fibrillation, Obesity, Weight Loss
Rijnstate Hospital
Phase 4
280
Arnhem, 's-Hertogenbosch, Alkmaar, Amsterdam, Breda, Deventer, Doetinchem, Eindhoven
2024-07-21
Recruiting
Erasmus Medical Center
Not applicable
50
Amsterdam, Groningen, Maastricht, Nijmegen, Rotterdam, Utrecht
2024-07-19
Recruiting
Amsterdam UMC, location VUmc
Not applicable
66
Emmen, Almere Stad, Valkenburg, Breda, Amsterdam, Heemskerk, Hilversum, Enschede
2024-07-19
Active, closed
Celldex Therapeutics
Phase 3
976
Amsterdam, Roosendaal, Utrecht
2024-07-19
Recruiting
Erasmus Medical Center
Not applicable
200
Breda, Capelle aan den IJssel, Leiden, Rotterdam
2024-07-18
Recruiting
Amgen
Phase 3
450
Amsterdam, Dordrecht, Enschede, Groningen, Maastricht, Utrecht
2024-07-17
Active, closed
Merck Sharp & Dohme LLC
Phase 1/2
38
Amsterdam
2024-07-17
Recruiting
Heidelberg University
Observational
4,000
Nijmegen
2024-07-16
Active, closed
Wageningen University
Not applicable
164
Wageningen
2024-07-16
Active, closed
A Study to Test the Effects and Safety of Riliprubart in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) for Which the Usual Treatments do Not Work
NCT06290128Chronic Inflammatory Demyelinating Polyradiculoneuropathy, Polyneuropathy, Inflammatory Demyelinating, Chronic
Sanofi
Phase 3
109
Amsterdam, Rotterdam
2024-07-12
Active, closed
GRIN Therapeutics, Inc.
Phase 1/2
30
Utrecht
2024-07-10
Recruiting
Dose Finding, Efficacy and Immunological Response of IP-001 Following MWA or IRE for CRLM
NCT06630624Colorectal Cancer, Liver Metastases, Liver Metastasis Colon Cancer
DrugIP-001
M.R. Meijerink
Phase 1/2
120
Amsterdam
2024-07-10
Recruiting
Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 or 2 Systemic Treatment Regimens
NCT06127407Locally Advanced or Metastatic Conventional Chondrosarcoma With an IDH1 Mutation, Untreated or Previously Treated With 1 Systemic Treatment Regimen
Servier Bio-Innovation LLC
Phase 3
156
Groningen, Leiden, Nijmegen
2024-07-09
Recruiting
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Observational
5,586
Amsterdam
2024-07-09
Recruiting
Detour: a Smartphone Game to Help Youth Quit Smoking
NCT06675526Smoking Cessation, Smoking Reduction, Adolescent Behavior, Social Behavior
Behavioural Science Institute
Not applicable
604
Nijmegen
2024-07-05
Recruiting
Multi-biomarkers in DEE
NCT07909382Developmental and Epileptic Encephalopathies (DEE)
Istituto Giannina Gaslini
Observational
200
Amsterdam
2024-07-04
Recruiting
AO Innovation Translation Center
Observational
600
Maastricht, Nijmegen
2024-07-03
Recruiting
DOSAGE Study: Upfront Dose-Reduced Chemotherapy in Older Patients with Metastatic Colorectal Cancer
NCT06275958Older Patients, Colorectal Cancer, Metastatic Cancer, Candidates for Palliative Chemotherapy
Leiden University Medical Center
Phase 3
587
's-Hertogenbosch, Alkmaar, Amstelveen, Amsterdam, Arnhem, Assen, Beverwijk, Doetinchem
2024-07-01
Recruiting
Bariatric Surgery Evaluation and Assessment of Treatment Efficacy - Intervention Trial
NCT06065124Heart Failure with Preserved Ejection Fraction, Atrial Fibrillation
University Medical Center Groningen
Not applicable
108
Arnhem, Groningen
2024-07-01
Recruiting
Erasmus Medical Center
Not applicable
30
Nijmegen, Maastricht, Amsterdam, Groningen, Rotterdam, Utrecht
2024-07-01
Active, closed
AstraZeneca
Phase 3
339
Breda, Rotterdam
2024-06-29
Recruiting
Curadel Surgical Innovations, Inc.
Phase 2/3
336
Groningen, Leiden, Rotterdam, Zwolle
2024-06-28
Recruiting
argenx
Phase 2/3
12
Leiden
2024-06-28
Active, closed
Novartis Pharmaceuticals
Phase 3
162
Almelo, Rotterdam
2024-06-28
Recruiting
University Medical Center Groningen
Not applicable
20
Groningen
2024-06-28
Recruiting
IRCCS Sacro Cuore Don Calabria di Negrar
Not applicable
278
Rotterdam
2024-06-28
Active, closed
Genmab
Phase 3
621
Amsterdam, Nijmegen, Utrecht
2024-06-25
Active, closed
Byondis B.V.
Phase 1
16
Groningen
2024-06-25
Active, closed
Novo Nordisk A/S
Phase 3
10,000
's-Hertogenbosch, Alkmaar, Amersfoort, Amsterdam, Arnhem, Breda, Eindhoven, Enschede
2024-06-25
Recruiting
Erasmus Medical Center
Phase 4
500
Rotterdam
2024-06-25
Recruiting
Absorbed Tumor Dose in Peptide Receptor Radionuclide Therapy with Long-acting Somatostatin Analogues - ATSA Trial
NCT06855095Neuroendocrine Tumors, Neuroendocrine Tumor Grade 1, Neuroendocrine Tumor Grade 2, Neuroendocrine Neoplasm
The Netherlands Cancer Institute
Phase 2/3
39
Amsterdam
2024-06-25
Recruiting
The RECLAIM Study.
NCT06450444Chronic Migraine, High Frequency Episodic Migraine
Salvia BioElectronics
Not applicable
110
Nieuwegein, Rotterdam
2024-06-24
Recruiting
Erasmus Medical Center
Observational
1,000
Rotterdam
2024-06-24
Recruiting
Atrial Flutter Ablation in the iCMR
NCT05904548Atrial Flutter Typical
Imricor Medical Systems
Not applicable
91
Amsterdam
2024-06-20
Active, closed
Ivy Brain Tumor Center
Phase 3
450
Maastricht, Utrecht
2024-06-19
Recruiting
Beam Therapeutics Inc.
Phase 1/2
192
Leiden
2024-06-19
By invitation
Sarepta Therapeutics, Inc.
Phase 1/2
60
Leiden
2024-06-19
Recruiting
The Netherlands Cancer Institute
Phase 1
37
Amsterdam
2024-06-18
Recruiting
UMC Utrecht
Phase 2
40
Utrecht
2024-06-18
Recruiting
Boehringer Ingelheim
Phase 3
6,712
's-Hertogenbosch, Arnhem, Breda, Deventer, Eindhoven, Gouda, Leiderdorp, Nieuwegein
2024-06-17
Active, closed
B-DIT Feasibility Study
NCT06471010Personality Disorders
De Viersprong
Observational
27
Halsteren
2024-06-17
Active, closed
Development and Validation of a New Paediatric Inflammatory Bowel Disease NUTrition Risk Score (PIBD-NUTS)
NCT06723418Inflammatory Bowel Diseases (IBD), Crohns Disease, Ulcerative Colitis (UC)
University of Glasgow
Observational
2,000
Rotterdam
2024-06-15
Recruiting
ABX advanced biochemical compounds GmbH
Phase 3
434
Nijmegen
2024-06-13
Recruiting
The Netherlands Cancer Institute
Phase 2
60
Amsterdam
2024-06-12
Recruiting
Radboud University Medical Center
Not applicable
200
Nijmegen
2024-06-10
Recruiting
UMC Utrecht
Observational
34
Utrecht
2024-06-10
Recruiting
Outcomes in Moderate Mixed Aortic Valve Disease
NCT06789211Mixed Aortic Valve Disease
Leiden University Medical Center
Observational
1,900
Leiden
2024-06-06
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,200
Nijmegen, Tilburg, Uden, Amsterdam, Rotterdam, Groningen, Utrecht
2024-06-05
Active, closed
Amgen
Phase 3
563
Groningen, Maastricht, Rotterdam
2024-06-05
Recruiting
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Not applicable
56
Amsterdam
2024-06-03
Recruiting
Arm Use With Soft-robotic Glove
NCT06033027Trauma Injury of Hand Multiple, Neurologic Disorder
Roessingh Research and Development
Not applicable
5
Enschede
2024-06-03
Recruiting
Hereditary Pheochromocytoma Assessment of Tumour Immunologies
NCT06444607Pheochromocytoma, Paraganglioma
Radboud University Medical Center
Observational
200
Nijmegen
2024-06-01
By invitation
The Role of the Human Microbiome in Patients After Pancreatic Resection.
NCT06381882Pancreas Cancer, Pancreas Neoplasm, Pancreas Adenocarcinoma, Periampullary Cancer
St. Antonius Hospital
Observational
200
Nieuwegein
2024-06-01
Active, closed
JointResearch
Observational
3,500
Amsterdam
2024-06-01
By invitation
Maastricht University Medical Center
Observational
500
Maastricht
2024-06-01
Recruiting
University Medical Center Groningen
Observational
80
Groningen
2024-06-01
Not yet open
Erasmus Medical Center
Not applicable
400
Rotterdam
2024-06-01
Recruiting
Prospective Registry of Patients Undergoing Cardiac CT With NAEOTOM Alpha PCD-CT Before TAVI Procedure
NCT07016477Coronary Artery Disease, Aortic Valve Stenosis, Tomography, X-Ray Computed
Semmelweis University
Observational
1,000
Maastricht
2024-06-01
Recruiting
Amsterdam UMC
Not applicable
20
Amsterdam
2024-05-31
Active, closed
ELVN-002 With Trastuzumab +/- Chemotherapy in HER2+ Solid Tumors, Colorectal and Breast Cancer
NCT06328738HER2-positive Breast Cancer, HER2-positive Gastric Cancer, HER2 Positive Solid Tumors, HER2 Amplification
Enliven Therapeutics
Phase 1
275
Nijmegen
2024-05-30
By invitation
Rijnstate Hospital
Observational
50
Arnhem
2024-05-29
Recruiting
Maastricht University Medical Center
Not applicable
11
Maastricht
2024-05-27
Recruiting
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
NCT06419374Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis
Hoffmann-La Roche
Phase 3
1,800
Amsterdam, Rotterdam, Tilburg, Utrecht
2024-05-24
Recruiting
RCT on T-REX Twente Regimen Effects on Quality of Life and Mobilisation for Cardiac Surgery Patients After Sternotomy
NCT06115759Sternotomy, Cardiovascular Diseases, Physical Inactivity, Quality of Life
Medisch Spectrum Twente
Not applicable
154
Enschede
2024-05-21
Recruiting
Daiichi Sankyo
Phase 3
540
's-Hertogenbosch, Amsterdam, Maastricht, Tilburg
2024-05-21
Active, closed
Syndax Pharmaceuticals
Phase 1
96
Utrecht
2024-05-21
Recruiting
VE303 for Prevention of Recurrent Clostridioides Difficile Infection
NCT06237452Clostridium Difficile, Clostridium Difficile Infections, Clostridium Difficile Infection Recurrence, Clostridioides Difficile Infection
Vedanta Biosciences, Inc.
Phase 3
852
Leiden, Utrecht
2024-05-20
Active, closed
Alnylam Pharmaceuticals
Phase 2
210
Amsterdam, Leiden, Nijmegen
2024-05-17
Recruiting
NMD Pharma A/S
Phase 2
84
Leiden
2024-05-16
Recruiting
Bidirectional Tuning of the AFO Stiffness
NCT06412055Neuromuscular Disorders
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Not applicable
10
Amsterdam
2024-05-15
Active, closed
The OPBC-07/microNAC Study
NCT06529302Breast Cancer
University Hospital, Basel, Switzerland
Observational
2,000
Amsterdam
2024-05-15
Recruiting
High Flow Nasal Oxygen for Exacerbation COPD
NCT06084117Acute Exacerbation of COPD
Franciscus Gasthuis
Not applicable
40
Delft, Rotterdam, The Hague
2024-05-14
Active, closed
European Myeloma Network B.V.
Phase 2
50
Nieuwegein, Rotterdam
2024-05-14
Recruiting
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 3
599
's-Hertogenbosch, Almere Stad, Amersfoort, Amsterdam, Apeldoorn, Arnhem, Assen, Beverwijk
2024-05-14
Recruiting
Spinal Cord Stimulation for Intractable Mononeuropathy
NCT06546371Mononeuropathies, Spinal Cord Stimulation
Erasmus Medical Center
Not applicable
12
Rotterdam
2024-05-13
Recruiting
Value of Screening MRI Brain in Stage IV Non-small Cell Lung Cancer
NCT05864794Non Small Cell Lung Cancer Metastatic
University Medical Center Groningen
Not applicable
100
Groningen, Maastricht, Scheemda
2024-05-13
Recruiting
W.L.Gore & Associates
Observational
2,000
Amsterdam, Tilburg, Venlo
2024-05-07
Recruiting
Treating Suicidality Remotely
NCT06370104Suicide Attempt
113 Suicide Prevention
Not applicable
364
Amsterdam
2024-05-07
Active, closed
University of Groningen
Not applicable
126
Assen, Zuidlaren, Leeuwarden
2024-05-06
Recruiting
Maastricht University
Not applicable
35
Maastricht, Leiden
2024-05-03
Recruiting
University of Birmingham
Phase 2/3
210
Utrecht
2024-05-02
Recruiting
The Netherlands Cancer Institute
Phase 2
72
Amsterdam
2024-05-02
Recruiting
PEM, a Starting Point to Investigate ME/CFS
NCT07715838Myalgic Encephalomyelitis / Chronic Fatigue Syndrome
University Medical Center Groningen
Observational
100
Groningen
2024-05-01
Active, closed
General Practitioners Research Institute
Observational
108
Groningen
2024-05-01
Active, closed
Erasmus Medical Center
Not applicable
103
Groningen, Rotterdam, Utrecht
2024-05-01
Active, closed
Eli Lilly and Company
Phase 3
10,000
Alkmaar, Almere Stad, Amersfoort, Amsterdam, Apeldoorn, Beverwijk, Breda, Dirksland
2024-04-30
Active, closed
Erasca, Inc.
Phase 3
78
Amsterdam, Leiden, Nijmegen
2024-04-29
Recruiting
CSL Behring
Phase 2/3
3,110
Apeldoorn, Eindhoven, Rotterdam
2024-04-27
Active, closed
Brief-intensive CBT Versus Once-weekly CBT in Anxiety-related Disorders
NCT05942391Anxiety Disorders, Obsessive-Compulsive Disorder, Posttraumatic Stress Disorder, Hypochondriasis
Amsterdam UMC, location VUmc
Not applicable
120
Amstelveen, Amsterdam, Haarlem, Hilversum, Hoofddorp, Utrecht
2024-04-26
Recruiting
A.J.C. Slooter
Not applicable
159
Nijmegen, The Hague
2024-04-24
Recruiting
The BRAINMAP-DBS Study: BRain Network AnalysIs usiNg 7-Tesla MRI and MAgnetoencephalograPhy for Deep Brain Stimulation
NCT06932692Deep Brain Stimulation, Parkinson Disease, Essential Tremor, Magnetoencephalography (MEG)
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Not applicable
500
Amsterdam
2024-04-23
Recruiting
Erasmus Medical Center
Not applicable
260
Rotterdam, Alkmaar, Breda, Dordrecht, Ede, Eindhoven
2024-04-23
Recruiting
Karyopharm Therapeutics Inc
Phase 2
58
Hoofddorp
2024-04-22
Recruiting
UMC Utrecht
Observational
300
Utrecht
2024-04-19
Recruiting
Graft Maturity After Blood Flow Restriction Training in ACL Reconstruction
NCT05972876Anterior Cruciate Ligament Reconstruction, Bone-Patellar Tendon-Bone Grafting
Zuyderland Medisch Centrum
Not applicable
46
Sittard
2024-04-17
By invitation
Amsterdam UMC, location VUmc
Not applicable
1,040
Amsterdam, The Hague
2024-04-17
Active, closed
A Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participants With Multiple Sclerosis.
NCT06372145Relapsing Multiple Sclerosis, Secondary Progressive Multiple Sclerosis, Progressive Relapsing Multiple Sclerosis
Sanofi
Phase 3
2,500
Amsterdam, Breda, Groningen, Heerlen
2024-04-16
Active, closed
argenx
Phase 3
119
Leiden, Utrecht
2024-04-16
Recruiting
Mucograft Seal in ARP Follow-up
NCT05663385Dental Implant
Erasmus Medical Center
Observational
75
Rotterdam
2024-04-16
Recruiting
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 1/2
112
's-Hertogenbosch, Alkmaar, Amersfoort, Amsterdam, Dordrecht, Ede, Eindhoven, Groningen
2024-04-15
Active, closed
Martini Hospital Groningen
Observational
146
Beverwijk, Rotterdam, Groningen
2024-04-15
By invitation
Intellia Therapeutics
Observational
100
Amsterdam
2024-04-12
Recruiting
CARE1 Pragmatic Clinical Trial
NCT06364631Metastatic Kidney Cancer, Metastatic Kidney Carcinoma
Gustave Roussy, Cancer Campus, Grand Paris
Phase 3
1,250
Amsterdam
2024-04-12
Recruiting
Deventer Ziekenhuis
Phase 4
29
Deventer
2024-04-12
Recruiting
The Netherlands Cancer Institute
Not applicable
31
Amsterdam
2024-04-12
Recruiting
AstraZeneca
Phase 3
3,850
Amsterdam, Arnhem, Emmen, Goes, Hardenberg, Leeuwarden
2024-04-12
Recruiting
International Extranodal Lymphoma Study Group (IELSG)
Observational
300
Arnhem
2024-04-11
Recruiting
Daiichi Sankyo
Phase 1/2
680
Amsterdam, Groningen, Nijmegen, Rotterdam, Utrecht
2024-04-10
Recruiting
Magnetic Resonance Imaging and Ultrasound Comparison With Load Evaluation
NCT06227182Muscular Dystrophy, Facioscapulohumeral
Radboud University Medical Center
Observational
100
Nijmegen
2024-04-10
Recruiting
Bronchial Thermoplasty for Adults With Severe Asthma in the Biologic Era
NCT07292805Asthma Exacerbations, Severe Asthma, Bronchial Thermoplasty
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Not applicable
90
Amsterdam, Groningen
2024-04-09
Recruiting
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Observational
90
Amsterdam
2024-04-08
Active, closed
Shape Memory Medical, Inc.
Not applicable
180
Arnhem, Tilburg, Amsterdam, Rotterdam
2024-04-05
Recruiting
Marc Bosiers, MD
Observational
109
Alkmaar, Arnhem, Groningen, Maastricht, The Hague
2024-04-05
Active, closed
A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis
NCT06329401Pulmonary Fibrosis, Progressive Pulmonary Fibrosis, Pulmonary Fibrosis Secondary to Systemic Sclerosis, Pulmonary Fibrosis, Interstitial Lung Disease
Avalyn Pharma Inc.
Phase 2
398
Nieuwegein, Rotterdam
2024-04-03
Recruiting
Learn to Dare! Leiden
NCT06609824Childhood Anxiety, Shyness
Leiden University
Not applicable
48
Leiden
2024-04-02
Recruiting
Mattienne van der Kamp
Not applicable
300
Enschede
2024-04-01
Recruiting
PerQseal® Elite Venous Clinical Study (ELITE-Venous)
NCT06007339Large Hole Percutaneous Venous Closure
Vivasure Medical Limited
Not applicable
90
Rotterdam
2024-04-01
Recruiting
Extensive Resection of Malignant Brain Tumors Using Advanced Imaging Techniques
NCT06623565Glioblastoma, Astrocytoma, IDH-Mutant, Grade 4
Amsterdam UMC, location VUmc
Not applicable
30
Amsterdam
2024-04-01
Recruiting
PRactice of VENTilation in Critically Ill PEDiatric Patients
NCT06220825Critical Illness, Respiratory Failure
University Medical Center Groningen
Observational
2,500
Groningen
2024-04-01
Recruiting
Potassium Correction for RAAS Optimization in Chronic Kidney Disease
NCT06256991Chronic Kidney Diseases, Hyperkalemia, Hypertension
University Medical Center Groningen
Phase 4
44
Groningen
2024-04-01
Recruiting
ECMO LEft Ventricle UNloading Strategy
NCT06766006Shock, Cardiogenic, Cardiac Arrest, Extracorporeal Membrane Oxygenation Complication
Maastricht University Medical Center
Observational
500
Maastricht
2024-04-01
Not yet open
Midline Restoration After HYbriD Hernia RepAir Surgery (HYDRA)
NCT06286124Incisional Hernia of Midline of Abdomen
Erasmus Medical Center
Observational
52
Leiden
2024-04
Active, closed
Study of Ravulizumab in Immunoglobulin A Nephropathy (IgAN)
NCT06291376Immunoglobulin A Nephropathy, IgAN
Alexion Pharmaceuticals, Inc.
Phase 3
584
Amsterdam, Rotterdam
2024-03-29
Active, closed
AstraZeneca
Phase 3
2,554
Alkmaar, Amersfoort, Dordrecht, Hardenberg, Harderwijk, Hilversum, Utrecht
2024-03-29
Recruiting
The Natural History and Muscle Fatigability of Patients With Congenital Myopathies.
NCT06157268Central Core Disease, Multi-Minicore Disease, Nemaline Myopathy, Centronuclear Myopathy
Radboud University Medical Center
Observational
100
Nijmegen, Utrecht
2024-03-28
Recruiting
Two-Fraction Ultrahypofractionated Radiotherapy With Focal Boost for Intermediate Risk, Localized Prostate Cancer
NCT06518226Prostate Cancer, Prostate Adenocarcinoma, Localized Prostate Carcinoma
UMC Utrecht
Not applicable
160
Utrecht
2024-03-28
Active, closed
MBT-early: a Single Case Experimental Design
NCT06212024Borderline Personality Disorder
De Viersprong
Observational
8
Halsteren
2024-03-27
Recruiting
Isala
Not applicable
211
Breda, Zwolle, Leeuwarden
2024-03-26
Recruiting
Italfarmaco
Phase 3
220
Hoofddorp, Enschede, Dordrecht
2024-03-26
Recruiting
Leiden University Medical Center
Not applicable
400
Groningen, Leiden, Maastricht, Sittard
2024-03-25
Recruiting
A Phase 1/1b Study of IAM1363 in HER2 Cancers
NCT06253871HER2 Mutation-Related Tumors, HER2, HER2-positive Breast Cancer, HER2 + Breast Cancer
Iambic Therapeutics, Inc
Phase 1
383
Amsterdam
2024-03-25
Recruiting
VU University of Amsterdam
Observational
60
Amsterdam
2024-03-25
Recruiting
Linda Douw
Not applicable
16
Amsterdam
2024-03-24
Active, closed
Essilor International
Not applicable
150
Rotterdam
2024-03-22
Recruiting
Molecure S.A.
Phase 2
96
Nieuwegein, Rotterdam
2024-03-21
Recruiting
Radboud University Medical Center
Not applicable
690
Hilversum, Amsterdam, Apeldoorn & Zutphen, Breda, Deventer, Ede, Eindhoven & Veldhoven, Emmen
2024-03-19
Recruiting
Verastem, Inc.
Phase 3
270
Amsterdam, Nijmegen
2024-03-18
Recruiting
Leiden University Medical Center
Phase 2
20
Leiden
2024-03-18
Recruiting
Erasmus Medical Center
Observational
1,000
Rotterdam
2024-03-18
Recruiting
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3
411
Leiden, Rotterdam, Tilburg
2024-03-15
By invitation
ENVISION IDE Trial: Safety and Effectiveness of NAVITOR in Transcatheter Aortic Valve Implantation
NCT05932615Aortic Valve Stenosis, Heart Valve Diseases, Aortic Valve Disease, Heart Disease Structural Disorder
Abbott Medical Devices
Not applicable
1,500
Groningen
2024-03-15
Recruiting
Maastricht University Medical Center
Not applicable
50
Maastricht
2024-03-14
Active, closed
Biohaven Therapeutics Ltd.
Phase 2/3
390
Heeze, Heemstede, Zwolle
2024-03-14
Recruiting
The Bipolar Lithium Imaging Scan Study.
NCT06134349Bipolar Disorder I or II
Leiden University Medical Center
Observational
80
Leiden
2024-03-13
Recruiting
Eli Lilly and Company
Phase 3
90
Rotterdam
2024-03-13
Recruiting
Janssen Research & Development, LLC
Phase 3
120
Rotterdam
2024-03-13
Recruiting
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
NCT06318169Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis
Hoffmann-La Roche
Phase 3
1,350
Rotterdam, Amsterdam, Utrecht
2024-03-13
Recruiting
Drug Rediscovery for Rare Immune Mediated Inflammatory Diseases
NCT06285539Behcet's Disease, Idiopathic Inflammatory Myopathies, IgG4-related Disease
UMC Utrecht
Phase 2
60
Amsterdam, Heerlen, Nijmegen, Rotterdam, The Hague, Utrecht
2024-03-12
Recruiting
Novartis Pharmaceuticals
Phase 3
450
Amsterdam
2024-03-12
Recruiting
The NEU-STIM Trial
NCT05942924Infant, Premature, Diseases, Birth, Preterm
Leiden University Medical Center
Not applicable
3,280
Leiden, Rotterdam
2024-03-11
Recruiting
Molecular Culture for the Diagnosis of Pediatric Sepsis
NCT06018792Sepsis, Sepsis Bacterial, Sepsis, Neonatal, Infection, Bacterial
Jip Groen
Observational
1,835
Amsterdam, Haarlem
2024-03-10
Recruiting
The Netherlands Cancer Institute
Phase 1/2
96
Amsterdam, Groningen, Leiden, Rotterdam, Utrecht
2024-03-08
Recruiting
Novartis Pharmaceuticals
Phase 2
502
Amsterdam, Rotterdam, Nieuwegein
2024-03-07
Recruiting
First-in-human Study of 225Ac-PSMA-Trillium (BAY 3563254) in Participants With Advanced Metastatic Castration-resistant Prostate Cancer (mCRPC)
NCT06217822Advanced Metastatic Castration-resistant Prostate Cancer, Prostate Specific Membrane Antigen (PSMA) Expression
Bayer
Phase 1
198
Rotterdam, Groningen
2024-03-07
Recruiting
Erasmus Medical Center
Not applicable
84
Amsterdam, Groningen, Maastricht, Nijmegen, Rotterdam
2024-03-06
Active, closed
Ryme Medical TLD Pilot Study
NCT05967091Chronic Obstructive Pulmonary Disease
Ryme Medical, Inc.
Not applicable
60
Groningen
2024-03-06
Active, closed
Eli Lilly and Company
Phase 3
17,300
Amersfoort, Amsterdam, Apeldoorn, Beverwijk, Delft, Deventer, Doetinchem, Ede
2024-03-05
Active, closed
Byondis B.V.
Phase 1
17
Amsterdam, Nijmegen
2024-03-04
Recruiting
Maastricht University Medical Center
Not applicable
27
Maastricht
2024-03-04
Recruiting
Majanka H. Heijenbrok-Kal, PhD
Not applicable
60
Rotterdam
2024-03-01
Active, closed
UMC Utrecht
Phase 2
35
Utrecht
2024-03-01
By invitation
Christian Dorfer
Observational
100
Utrecht
2024-03-01
Recruiting
Amsterdam UMC
Not applicable
654
Amsterdam, Almelo, Apeldoorn, Arnhem, Eindhoven, Groningen, Heerlen, Leeuwarden
2024-03-01
Recruiting
Erasmus Medical Center
Phase 4
500
Rotterdam
2024-03-01
Recruiting
Esketamine as Treatment for Chronic Pain Due to Endometriosis: a RCT Study
NCT06161805Endometriosis, Chronic Pelvic Pain Syndrome
Reinier de Graaf Groep
Phase 3
56
Delft
2024-03-01
Recruiting
DSM-5 Personality Disorders in Adults With Autism
NCT06726187Autism Spectrum Disorder
Parnassia Groep
Observational
102
Rotterdam
2024-03-01
Recruiting
Maastricht Radiation Oncology
Observational
100
Maastricht
2024-02-29
Recruiting
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
NCT06172478Advanced Solid Tumor, Melanoma, Head and Neck Cancer, Gastric Cancer
Daiichi Sankyo
Phase 2
740
Amsterdam, Groningen, Leiden, Maastricht, Nijmegen
2024-02-26
Recruiting
Aleksander Krag
Phase 3
240
Leiden, Leiderdorp
2024-02-26
Recruiting
Alert Frequency, Nurse, and Patient Satisfaction With a wCVSM Software Across Health Care Systems and Cultures
NCT06289699User Experience, Postoperative Complications, Acute Medical Conditions
Christian S. Meyhoff
Observational
100
Groningen
2024-02-26
Active, closed
Franciscus Gasthuis
Not applicable
420
Rotterdam
2024-02-26
Active, closed
Dianthus Therapeutics
Phase 2
65
Amsterdam
2024-02-23
Recruiting
Pulmonx Corporation
Not applicable
200
Groningen
2024-02-22
Active, closed
Seagen, a wholly owned subsidiary of Pfizer
Phase 3
762
Groningen, Maastricht, Rotterdam
2024-02-21
Active, closed
Vertex Pharmaceuticals Incorporated
Phase 1/2
47
Maastricht
2024-02-20
Recruiting
Nick Beije
Phase 3
400
Alkmaar, Amersfoort, Amsterdam, Assen, Beverwijk, Deventer, Eindhoven, Emmen
2024-02-20
Recruiting
Erasmus Medical Center
Observational
150
Rotterdam
2024-02-20
Active, closed
Novo Nordisk A/S
Phase 2
88
Groningen, Utrecht
2024-02-20
Recruiting
Appropriate Use of Blood Cultures in the Emergency Department Through Machine Learning
NCT06163781Artificial Intelligence, Machine Learning, Microbiology, Emergency Service, Hospital
Amsterdam UMC, location VUmc
Not applicable
7,584
Amsterdam
2024-02-19
Recruiting
Italfarmaco
Phase 3
138
Leiden, Nijmegen
2024-02-19
Active, closed
Stage II-IIIa Urothelial Cancer Randomizing Pre-operative Nivolumab With or Without Relatlimab
NCT06237920Urologic Neoplasms, Urogenital Neoplasms, Neoplasms by Site, Neoplasms
The Netherlands Cancer Institute
Phase 2
90
Arnhem, Nijmegen, Amsterdam, Hoofddorp, Zwolle, Leiden, Rotterdam, Utrecht
2024-02-19
By invitation
Maastricht University Medical Center
Observational
100
Maastricht
2024-02-19
Recruiting
Amicus Therapeutics
Observational
500
Rotterdam
2024-02-16
Active, closed
Bayer
Observational
2,500
Multiple Locations
2024-02-15
Recruiting
eGPA and Local Inflammation Within the Ear, Nose and Throat Area
NCT06298448EGPA - Eosinophilic Granulomatosis With Polyangiitis
University Medical Center Groningen
Observational
150
Groningen
2024-02-14
Recruiting
UMC Utrecht
Not applicable
350
Utrecht
2024-02-14
Recruiting
Nutricia Research
Observational
172
Utrecht
2024-02-13
Recruiting
Multicenter Registry of Patients With Subarachnoid Hemorrhage
NCT07482124Subarachnoid Hemorrhage, Spontaneous
UMC Utrecht
Observational
1,000
Nijmegen, Maastricht, Tilburg, Amsterdam, Zwolle, Groningen, Rotterdam, The Hague
2024-02-12
Recruiting
St. Antonius Hospital
Phase 2
92
Delft, Nieuwegein
2024-02-12
By invitation
Non-invasive Detection of Driveline Infections in Patients with a Left Ventricular Assist Device
NCT06867887LVAD (Left Ventricular Assist Device) Driveline Infection
Erasmus Medical Center
Observational
70
Rotterdam
2024-02-12
Active, closed
Boehringer Ingelheim
Phase 3
428
Amsterdam, Maastricht
2024-02-09
Recruiting
BioClock: Bright Light Therapy for Depressive Disorders
NCT05958940Depression, Unipolar, Depression, Bipolar
Universiteit Leiden
Not applicable
231
Eindhoven, Leiden
2024-02-08
Rows per page Showing 1001–1500 of 3171
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Dutch investigative site. Derived from ClinicalTrials.gov. Retrieved 12 November 2026. https://priyalifescience.com/clinical-trials-netherlands?page=3

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Netherlands and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 3,171 studies in total at the last sync on 10 Nov 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

How many clinical trials are recruiting in Netherlands?

1,789 of the 3,171 studies in this register are recruiting new participants as of the 10 Nov 2026, 03:17 UTC sync. A further 187 have not yet opened recruitment, 1,082 are active but closed to new participants, and 113 are enrolling by invitation only. Eligibility for any study is decided by its study team.

This register, in your inbox every Friday

One email a week with how many trials are recruiting in Ireland, new EMA and FDA approvals and medicine shortages, built from the same public registers as this page.

Free. Unsubscribe from any email with one click. See our privacy policy.

→

Browse trials by condition

Breast Cancer (59) Prostate Cancer (44) Heart Failure (39) Multiple Myeloma (39) Coronary Artery Disease (37) Carcinoma, Non-Small-Cell Lung (26) Cancer (25) Atrial Fibrillation (24) Obesity (23) Crohn's Disease (23) Colorectal Cancer (22) Glioblastoma (22) Ulcerative Colitis (21) Cardiovascular Diseases (20) Melanoma (20)
→

Browse trials by site location

Amsterdam (1239) Rotterdam (853) Groningen (601) Nijmegen (565) Utrecht (543) Maastricht (420) Leiden (385) Eindhoven (208) Arnhem (182) Breda (172) Nieuwegein (149) The Hague (121) 's-Hertogenbosch (119) Tilburg (114) Zwolle (109)
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.